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Chapter I 
General translation and its control in prokaryotes 
 
 
1.1. The central dogma 
 Almost every biological phenomenon, of which scientists are aware, is a 
consequence of the interplay among three macromolecular polymers: DNA, RNA, and 
Protein. So essential is this to our understanding of the microscopic world that we have 
dubbed the process of transitioning from one type of polymer to another the “Central 
Dogma”. To over-simply restate the tenet: the hereditary material, DNA, can be faithfully 
replicated to make a perfect copy of itself for the next generation, or it can be 
transcribed into RNA. Once transcribed, RNA may act as the final product, capable of 
performing some vital function, be reverse-transcribed back into a DNA molecule, or, in 
the case of messenger RNA (mRNA), it may be translated into a protein product (Figure 
1.1). It is this process of translation which will be the focus of the first half of the 
discussion to follow, specifically, the general process of faithful translation, the 
accessory factors involved, and the targeted regulation of specific mRNAs in the 
bacterium Escherichia coli. Though the process of translation is generally well 
conserved up the evolutionary ladder, there are some key differences between 
prokaryotes and eukaryotes which will not be discussed here (For review see [1, 2]), 
and this document will focus on the mechanisms of translation in prokaryotes.
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1.2. The structure and assembly of the ribosome 
 The ribosome is a large complex of ribosomal RNAs (rRNAs) and proteins which 
come together to form a structure with a sedimentation coefficient of 70S. Further, the 
translating unit is a complex of a large and a small subunit of sizes 50S and 30S 
respectively [3, 4]. Though the exact numbers depend upon the isolation conditions 
used during purification, the large subunit contains about 33 proteins and two rRNAs. 
These rRNAs themselves have sedimentation coefficients of 23S and 5S. The small 
subunit contains about 22 proteins and one 16S rRNA. 
 Because of the importance of the ribosome, many resources are dedicated to its 
assembly. In total, it is estimated that rRNA comprises over 90% of the total RNA 
present at any given time in the E. coli cytosol [5]. The three rRNAs are transcribed 
polycistronically from seven different operons [6] (Figure 1.2 [7]). The multiple loci allow 
high levels of expression of rRNA genes during logarithmic growth, and the polycistronic 
nature of the genes helps to maintain the proper stoichiometry. Once transcribed, these 
rRNAs undergo processing which includes cleavage into pre-rRNAs, as well as 
subsequent trimming into mature rRNAs (For review see [7]), and post-transcriptional 
modifications such as pseudouridylation and methylation (Figure 1.3 [8]). 
 As mentioned, the ribosome is a large ribonuclear protein complex which, in 
addition to 3 rRNAs, contains over 50 proteins (r-proteins). Like the rRNAs, many of 
these proteins are located within operons across the E. coli genome. Though the 
mRNAs encoding r-proteins themselves are not processed, expression of r-proteins is 
also highly regulated, in order to maintain stoichiometry. Cleverly, r-proteins use 
feedback mechanisms to regulate their own expression, often decreasing the 
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translational efficiency of their own mRNAs or attenuating the transcription of their 
operons (For review see [9]).  
 Even with all of the parts present at the proper ratios, the ribosome still needs 
assistance in order to properly assemble. In vitro, the ribosome can be assembled from 
all of its individual components, and complex maps have been constructed based on the 
information obtained from the interdependency of r-proteins for assembly into the 
finished ribosomes [10]. Unfortunately, this in vitro assembly requires non-physiological 
temperatures, magnesium concentrations, and timescales. In vivo efficient assembly is 
facilitated by ribosome associated factors (RAFs) which catalyze assembly [11]. In 
some cases, deletion of these factors leads to inviability. In other cases, perturbation of 
ribosomal structure is observed, usually manifested as a change in the sedimentation 
coefficient of one of the subunits. This may or may not lead to an accumulation of the 
other ribosomal subunit and a concurrent decrease in 70S ribosomes and polysomes 
(more than one ribosome bound to a single mRNA) [12, 13]. 
 
1.3. Translation in three stages 
 As with any “heavy machinery”, there are considerations for starting, operating, 
and shutting down the engine. Analogously, translation can be broken down into its 
three main phases: initiation, elongation, and termination. Initiation of translation 
involves binding of the small (30S) subunit to the mRNA, recruitment of the first charged 
tRNA, and coupling of the large (50S) subunit to form the complete 70S ribosome. 
Elongation starts with the arrival of the second charged tRNA, formation of a peptide 
bond between the growing polypeptide chain and the newly recruited amino acid, and 
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movement of the ribosome along the mRNA. This stage of translation continues until a 
signal is reached in the mRNA which triggers the final step: termination. During 
termination, three things must occur. The nascent protein must dissociate from the 
ribosome. The subunits must separate, and the mRNA must be released. These 
individual stages of translation, as well as the factors which facilitate the accurate and 
timely completion of the same, have been exhaustively studied. Here I will describe 
each stage in more detail, as well as discuss the canonical factors involved at each 
step. This background will help to place the hypothesized mRNA-specific regulation of 
translation by the E. coli protein ProQ into the context of the entire process. 
 
1.3.1. Translation initiation and initiation factors 
 In eukaryotes, initiation of translation, with some exceptions, involves the 
recognition of a 5’ methylguanosine “cap” structure on the mRNA. Once located, the 
ribosome is able to scan for the start site for translation and begin synthesizing protein 
[14]. In prokaryotes, mRNA processing is less common, and this 5’ cap structure is not 
present. Instead, a sequence within the mRNA called the Shine-Dalgarno sequence is 
recognized by a complementary sequence in the 16S rRNA of the 30S subunit. Base 
pairing between these sequences positions the small ribosomal subunit over the start 
site for translation. An analogous sequence, called the Kozak sequence, exists in 
eukaryotes, but the sequence is more degenerate than that of the Shine-Dalgarno 
sequence [15, 16]. Once the 30S subunit is positioned, the rest of the translating 
complex must be assembled on the mRNA. This includes recruitment of the initiator 
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tRNA to the mRNA at the first codon and coupling of the 50S to the 30S/mRNA complex 
(Figure 1.4 [17]). 
 There are three core initiation factors in E. coli, appropriately named IF1, IF2, 
and IF3. In addition, the first transfer RNA (tRNA), which brings with it the first amino 
acid, in slightly different than the “normal” tRNAs which bring the subsequent amino 
acids necessary for peptide synthesis during the elongation phase. These factors help 
to ensure that initiation occurs with speed and accuracy. IF3 is the first factor to interact 
with the 30S ribosome during initiation. Binding of IF3 to the 30S subunit precludes 50S 
binding and premature formation of the 70S complex [6]. This ensures that the mRNA, 
as well as the other initiation factors can bind to the 30S and form a competent initiation 
complex.  
 It is important, here to note that amino acid-carrying tRNAs (also called charged 
tRNAs) can be found in one of three locations in the ribosome, at the interface between 
the 30S and 50S subunits. The first site is the peptidyl transferase site (P-site). Here, 
the newly arriving amino acids are added to the growing protein. It is also the site of 
binding of the initiator tRNA, which will be discussed in detail later. The other two sites 
are the acceptor site (A-site), and the exit site (E-site). The A-site is the location of initial 
binding for the charged tRNAs as they bring the amino acids to the ribosome, and the 
E-site allows the uncharged tRNA to dissociate from the ribosome (Figure 1.5, For 
review see [18]). 
 After binding of IF3 to the 30S subunit, mRNA can bind to the 30S subunit via 
base pairing between the Shine-Dalgarno sequence in the mRNA and the 16S rRNA, as 
previously mentioned. Once the mRNA is positioned, the initiator tRNA can be brought 
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to the P-site by IF2. The initiator tRNA carries a specially modified methionine residue 
which is formylated. This formylmethionine (fmet) is what is recognized by IF2 [19]. 
Other regions of the tRNAfmet are also altered slightly when compared to non-initiator 
tRNAs. Presumably, these alterations facilitate initiation complex formation [20, 21]. For 
its part, IF1 helps to stabilize the formation of the completed 30S preinitiation complex 
by assisting in the positioning of the initiator tRNA by IF2 and the blocking of 50S 
association by IF3 [22].  
 In the final stages of initiation, the 50S must be joined to the 30S subunit, and the 
initiation factors must leave the ribosome. After IF3 dissociates, the 50S can bind. IF1 
then leaves the ribosome. IF2 has GTPase activity, and hydrolysis to GDP by IF2 
provides the energy to lock the initiator tRNA into its final position and prime the 
ribosome to begin translation. At this point, IF2 leaves the initiated ribosome, and the A-
site is available for new charged tRNAs to bind [23]. 
 
1.3.2. Translation elongation and elongation factors 
 The elongation phase of translation requires the coordination of several 
processes. First, the correct charged tRNA must be brought to the A-site of the 
ribosome. The amino acid on that tRNA must be transferred to the nascent protein, and 
the ribosome must move along the mRNA. The catalysis of the addition of the new 
amino acid to the growing chain is carried out by the enzymatic activity of the ribosome. 
Specifically, the 23S rRNA possesses peptidyl transferase activity [24]. The other steps 
are facilitated by another suite of factors called elongation factors. Again, I will discuss 
the action of three factors: EF-Tu, EF-Ts, and EF-G. 
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 EF-Tu is responsible for assisting with the first step of elongation, where the 
charged elongator tRNA is brought to the A-site of the ribosome, positioning it for 
incorporation into the growing polypeptide chain. In this way, EF-Tu is analogous to IF2, 
in that it binds to the charged tRNA and brings it to the ribosome [25, 26]. Additionally, 
like IF2, EF-Tu is a GTPase. Once EF-Tu positions the tRNA in the A-site, and a match 
is made between the codon in the mRNA and the anticodon of the tRNA, GTP is 
hydrolyzed to GDP by EF-Tu. GDP-bound EF-Tu has decreased affinity for the 
ribosome and tRNA, and it dissociates [27]. Transfer of the growing polypeptide and 
formation of a peptide bond between the elongating peptide and the A-site tRNA-bound 
amino acid is catalyzed by the ribosome [24]. Simultaneously, it is necessary for the P-
site and A-site tRNAs to shift to the E-site and P-site respectively in a process called 
translocation.  
 Translocation is often described as a “ratcheting” motion. Because of this ratchet, 
tRNAs often exist in hybrid states, occupying different positions in the 50S subunit 
relative to the 30S subunit. These states are often referred to as the P/E and A/P states. 
The elongation factor EF-G helps to facilitate this ratchet by binding near the A-site of 
the ribosome. Like EF-Tu, EF-G is a GTPase. Hydrolysis of GTP to GDP by EF-G 
moves the translocation process through the P/E and A/P intermediate states, 
culminating in the P-site tRNA moving to the E-site and the A-site tRNA moving to the 
P-site [28, 29]. Finally, EF-G leaves the ribosome and the A-site is available for binding 
of the next charged tRNA (Figure 1.6 [30]).  
 Again, EF-Tu is responsible for bringing the next charged tRNA to the ribosome, 
but it has lowered affinity for charged tRNA in its GDP bound state. The last elongation 
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factor, EF-Ts is a nucleotide exchange factor. It helps to dissociate “spent” guanine 
nucleotides from EF-Tu. Once EF-Ts facilitates the release of GDP from EF-Tu, EF-Tu 
is able to bind to GTP, and the cycle continues [31]. 
 
1.3.3. Translation termination and termination factors 
 Elongation of translation continues until the ribosome reaches a signal in the 
mRNA which causes translation to cease: a stop codon. Like other amino acid-
determining codons, it is a triplet of bases in the mRNA, but it does not code for the 
incorporation of an amino acid, rather it causes the ribosome to pause, allowing 
termination to occur. Three unique stop codons exist, though all contain a uracil at the 
first position: UAA, UAG, and UGA [32, 33]. 
 Upon encountering a stop codon, several steps occur. First, the protein is 
released from the P-site tRNA. The subunits dissociate from each other and the mRNA 
is released. The first step is facilitated by release factors 1, 2, and 3 (RF1/2/3) (Figure 
1.7 [30]). Dissociation of the subunits and the mRNA is stimulated by ribosome 
recycling factor (RRF) as well as IF3 and EF-G [34]. 
 To recognize a stop codon, E. coli use RF1 and RF2 to function semi-
redundantly. Both RF1 and RF2 recognize the UAA codon. RF1 alone recognizes UAG, 
and RF2 recognizes UGA [35, 36]. Structurally, RF1 and RF2 resemble the anticodon 
loop of tRNA. This is not surprising as the RFs bind at the A-site of the ribosome. Once 
the stop codon is recognized by one of the RFs, hydrolysis of the peptide bond between 
the P-site tRNA and the protein is catalyzed. Three conserved amino acids in the RFs, 
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termed the GGQ motif, facilitate this hydrolysis in the peptidyl transferase center of the 
ribosome, and the peptide is released [37]. 
 Release of RF1 or 2 occurs after RF3 binds to the ribosome (Figure 1.7 [30]). 
RF3 is also a GTPase, and GTP hydrolysis is important for its dissociation from the 
ribosome, but the current literature seems unclear as to whether RF3 binds to the 
ribosome in its GDP or GTP bound state and whether or not it requires a GEF [38, 39]. 
Once RF1/2 has been released, the subunits are dissociated by the actions of RF3 and 
EF-G. There are conflicting reports as to whether the tRNA and mRNA are dissociated 
at this time as well or if the action of IF3 is required for removing the remaining tRNA 
and mRNA [34, 40]. In either case, the three factors: RF3, EF-G, and IF3, work together 
to stabilize the dissociated subunits, freeing them for another round of initiation. 
 
1.4. Examples of mRNA specific translational control 
 The factors described above are often termed “general translation factors”, as 
they exert their control over the process as a whole, rather than specific mRNAs. In 
addition to these factors, there are a suite of RNA-RNA and Protein-RNA interactions 
which regulate the translation of a subset of messages. In the following sections, I will 
discuss three such cases of Protein-RNA (and in some cases Protein-RNA-RNA) 
interactions which work in this manner. This will serve as a primer for Chapter II of this 
document, as my work in the Maddock Lab examined the E. coli protein ProQ, a factor 
hypothesized to regulate the translation of a subset of mRNAs. 
 
1.4.1. Hfq, small RNAs, and translational control 
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 Hfq is a well conserved protein which appears in the genomes of many different 
bacteria. It is relatively small (102 AA in E. coli), but it has a large effect on gene 
expression, especially under cellular stress conditions [41]. Hfq is said to possess RNA 
chaperone activity, defined as the ability to alter the shape of an RNA in such a way as 
to functionalize it [42]. The main role of Hfq is to facilitate binding between small RNAs 
(sRNAs) and their target mRNAs. In some cases, this pairing leads to the degradation 
of the mRNA and decreased expression [43, 44]. In other cases, this interaction can 
amplify the expression of a gene by increasing the mRNA half-life or facilitating more 
efficient translation [45, 46]. 
 An example of Hfq negatively regulating translation is in the target recognition of 
the sRNA RhyB. RhyB is transcribed to high levels when iron levels are low. Once 
transcribed, RhyB helps to target iron-binding and storage protein mRNAs for 
degradation [44, 47]. It was later found that, in the absence of Hfq, RhyB sRNA is 
unstable. In this way, Hfq regulates translation of specific messages by binding to a 
sRNA and increasing its stability, as well as helping it to find its targets and direct 
RNase cleavage by RNaseE [43]. 
 Hfq can have a stimulatory effect on translation as well. The stationary sigma 
factor RpoS contains a hairpin structure within its 5’ UTR. This hairpin structure blocks 
binding of the ribosome to the Shine-Dalgarno sequence by keeping it in a double 
stranded moiety. The sRNA DsrA can base pair with the 5’ UTR of RpoS and make the 
message competent for translation. This interaction is stabilized by Hfq, and RpoS 
protein levels are decreased in an hfq mutant strain (Figure 1.8 [45, 46]). 
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1.4.2. FinO, finP, and traJ 
 The protein product encoded by the traJ gene is a transcription factor involved in 
the transfer of DNA between bacteria, a process called conjugation. The finP gene 
encodes for a sRNA which has inhibitory effects on traJ expression. Analogous to the 
RhyB and DsrA/RpoS systems, this effect is mediated by a physical interaction between 
complementary sequences on the two RNAs which blocks the Shine-Dalgarno 
sequence of traJ [48]. For its part FinO stabilizes this interaction [49, 50]. 
 FinOP repression of traJ expression is also dependent upon RNaseE and RNase 
III. The evidence suggests that binding of FinO to finP RNA prevents degradation by 
RNaseE, a single stranded ribonuclease. Additionally, finP-traJ duplexed DNA can be 
digested by RNase III, a double stranded ribonuclease [48, 51]. 
 
1.4.3. sRNA independent regulation by TRAP 
 The two previous examples discussed the importance of small RNAs, proteins, 
and nucleases in the regulation of translation. Other mechanisms exist which are more 
direct. One such example from Bacillus subtilis is the attenuation of tryptophan 
metabolism genes by direct binding of the protein TRAP at or near the ribosome binding 
site [52, 53]. Other studies have shown that TRAP does not need to physically block the 
RBS itself, but it can bind and influence the secondary structure of the mRNA to block 
the RBS from a distance [54]. TRAP is regulated by an anti-TRAP protein which is 
expressed when levels of tryptophan are low. This protein binds to TRAP and prevents 
it from binding to the mRNA [55]. 
1.5. Summary 
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 Translation is a regulated process which requires the allocation of much of the 
cell’s time and energy. Additionally, tight controls are in place at all steps, from 
assembly to termination, to ensure that the process is completed in a highly faithful 
manner. Much effort and many resources have been employed in the study of “just” the 
canonical factors which facilitate all stages. 
 In addition to the traditional factors and mechanisms, translation of specific 
mRNAs can be tightly regulated by other factors. In general, these factors serve one of 
two over-simplified functions. They change the stability of an RNA, or they modify the 
ability of the mRNA to interact with the ribosome itself. 
 In the next chapter, I will discuss the E. coli protein ProQ, its association with the 
ribosome, and its potential role as a messenger specific translation factor. 
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Figure 1.1. The Central Dogma of Molecular Biology. The central dogma describes 
the flow of important genetic/cellular information through the indicated biological 
processes to affect cell function. 
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Figure 1.2. Organization of the 7 rRNA operons in Escherichia coli. The genes 
encoding the 3 ribosomal RNAs (rRNA) and some transfer RNA (tRNA) genes are 
transcribed from seven operons. All operons contain at least one copy of all three rRNA 
genes and at least one additional tRNA gene. Shown are the operon names, the rRNA 
genes (red boxes) and the tRNA genes (colored boxes). The tRNA genes are shown in 
the key below the operon diagrams. (Adapted from [7]). 
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Figure 1.3. Base modifications of ribosomal RNAs. Proper assembly and function of 
the ribosome is dependent upon modifications of the ribosomal rRNAs. Uridine bases 
can be isomerized to form pseudouridines by pseudouridine synthases [56, 57]. 
Additionally, the 2’ oxygen can be methylated by uridine methyltransferases [58]. 
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Figure 1.4. Initiation of translation. Proper formation of the 70S initiation complex is 
facilitated by three initiation factors and the intiator tRNA. First, Interaction between IF3 
and the 30S subunit blocks the binding of the 50S. Then, the Shine-Dalgarno sequence 
in the 5’ end of the mRNA is recognized by a complementary sequence in 16S rRNA of 
the 30S subunit. The initiator tRNA is then brought to the ribosome by IF2, and IF1 
helps to position the tRNA and stabilize the 30S preinitiation complex. After IF3 
dissociates, the 50S subunit can bind. Subsequently, IF1 and IF2 leave the 70S 
initiation complex, leaving only the initiator tRNA in the P-site of the ribsome. Elongation 
can then proceed. Adapted from [17]. 
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Figure 1.5. Cartoon of tRNA occupied sites on the E. coli ribosome. The interface 
of the 30S and 50S subunits forms three distinct sites which are occupied by different 
tRNA species.  
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Figure 1.6. The translocation cycle. During elongation, tRNAs simultaneously occupy 
different ribosome sites in the small and large subunit. Movement of tRNAs through 
various hybrid states is facilitated by EF-G and its GTP hydrolysis activity. Adapted from 
[30]. 
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Figure 1.7. Termination of translation. At termination, either RF1 or RF2 recognizes a 
stop codon toward the 3’ end of an mRNA. Hydrolysis causes liberation of the peptide, 
and RF3 binds to help promote termination via its GTP hydrolysis activity. Once RF1/2/3 
leave, dissociation of the subunits and mRNA is facilitated by Ribosome Release Factor 
(RRF). Additionally, IF3, as mentioned previously, as well as EF-G maintain the 
ribosome as dissociated subunits and prevents reformation of 70S complexes. Adapted 
from [30]. 
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Figure 1.8. Control of rpoS translation by a small RNA (sRNA) and Hfq. The 5’ end 
of the rpoS mRNA contains secondary structure such that the Shine-Dalgarno (SD) 
sequence is base paired with a complementary sequence (anti-SD). This prevents 
association of the 30S subunit. An sRNA containing an anti-anti-SD sequence, with the 
help of the RNA chaperone Hfq, can help to dissolve this secondary structure, exposing 
the SD-sequence and allowing the 30S to bind. Adapted from [46]. 
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Chapter II 
Analysis and expansion of the role of the Escherichia coli protein ProQ 
 
This chapter has been published as, and modified from: 
Sheidy DT, Zielke RA (2013) Analyss and Expansion of the Role of theEscherichia 
coli Protein ProQ. PLoS ONE 8(10): e79656.  
 
 
2.1 Introduction 
 
 The maintenance of osmotic balance is essential for the fitness and survival of 
bacteria. One mechanism used by prokaryotes to achieve this balance in hyperosmotic 
environments is the import of osmoprotectant molecules which balance internal and 
external osmolarity and prevent the flow of water out of the cell [for review see [1]]. 
Several membrane bound transporters exist with a variety of specificities for different 
molecules. One such transporter, ProP, senses hyperosmotic stress, and responds by 
importing proline and glycine betaine [2-4]. Examination of the transcriptional regulation 
of proP has revealed a complex network of both growth-phase and osmolarity 
dependent control. Briefly, proP transcription can occur from a proximal (P2) or distal 
(P1) promoter [5]. Transcription from the P2 promoter occurs as cells transition from the 
logarithmic-growth phase into stationary phase and is dependent upon the stationary-
phase sigma factor RpoS. Transcription from the P2 promoter is further enhanced by 
the nucleoid-associated factor Fis [6,7] and cyclic AMP receptor protein (CRP) [6]. The 
binding of Fis and CRP inhibit transcription from the P1 promoter [7, 8]. The P1 
promoter is activated after subculture into fresh media, and is responsible for 
responding to upshifts in media osmolarity [5, 8, 9].
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  Beyond transcription, ProP activity is modulated by the cytoplasmic effector ProQ 
[10]. ProQ is a 232-residue protein, predicted to contain two structural domains, 
tethered by an unstructured linker [11, 12]. The N-terminal domain has been modeled 
on the structure of the RNA-binding, translational regulator FinO [11, 13], and the C-
terminal domain has been modeled on the RNA chaperone Hfq [14]. Biochemical 
studies have been performed to support the structural predictions. The FinO-like 
domain, as well as the full length protein, are capable of binding to a model dsRNA 
template. The FinO-like domain also facilitates strand exchange, and both domains 
promote duplexing between complimentary strands of RNA [14]. Thus, ProQ behaves 
as an RNA chaperone. The mechanism behind ProQ regulation of ProP activity, 
however, remains largely unknown. Disruption of the proQ locus has no effect on the 
transcription of proP, but the proline uptake activity of ProP is significantly decreased in 
a ΔproQ strain [10, 15]. A post-translational mechanism was initially proposed after 
ProP protein levels appeared unchanged in a ΔproQ strain [15]; however, a direct 
physical interaction between ProP and ProQ has not been found. Most recently it was 
shown that, at osmolalities lower than those previously examined, ProP levels are 
decreased in a proQ mutant [14]. Additionally, as cells enter stationary phase, there is a 
modest decrease in the level of ProP in a proQ mutant compared to wild type [14]. In 
light of these findings, and the homology models comparing the ProQ domains to known 
RNA-binding proteins, a post-transcriptional mode of regulation is likely. 
  It had been reported in a high throughput study that ProQ was associated with 
ribosomes [16]. This led to the hypothesis that ProQ regulates ProP activity at the level 
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of translation. In this study, we verify that ProQ is associated with ribosomes in vivo, 
and we characterize this association under various conditions. We also determine which 
domains of ProQ are important for association. We demonstrate that ProQ binds tightly, 
but non-selectively to in vitro transcribed proP mRNA, and we report the KD values for 
P1, P2, and an mRNA whose translation is not predicted to be dependent upon ProQ. 
Though we demonstrate that mRNA integrity is important for the association of ProQ 
with translating ribosomes, disruption of the proP locus, as well as the closely related 
proU operon, does not affect ProQ localization in polysome profiles. It had also been 
reported in a high throughput study that a proQ mutant exhibits decreased biofilm 
formation. Here we verify that result by complementing the phenotype and show that a 
proP mutant strain is not defective in biofilm formation. It follows that ProQ may act as a 
translation factor for a broader subset of mRNAs. 
 
2.2. Materials and methods 
2.2.1. Bacterial strains and growth conditions 
E. coli strains used in this study are listed in Table 1. Strains were grown at 37oC 
in Luria-Bertani (LB) broth (10 g tryptone, 5 g yeast extract, 10 g NaCl per liter). 
Cultures of JM6733 containing plasmids were supplemented with 20 µg/mL 
chloramphenicol (BioExpress). JM6733 (ΔproQ::KAN), JM6753 (ΔproP::KAN), JM6754 
(ΔproV::KAN), JM6755 (ΔproW::KAN), and JM6877 (ΔproX::KAN) were constructed by 
P1 transduction [17] of KEIO-collection mutants, JW5300, JW4072, JW2652, JW2653, 
and JW2654 respectively, into a clean BW25113 background [18]. JM6881 
(ΔproVWX::KAN) was made using the λred recombination system [19]. JM6906 
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(ΔproP::FRT) was constructed by transformation of JM6753 (ΔproP::KAN) with pCP20, 
and subsequently, screening for sensitivity to kanamycin [20]. JM6926 (ΔproP::FRT, 
ΔproVWX::KAN) was constructed by P1 transduction of JM6906 by phage grown on 
JM6881. Genotypes were verified using primers flanking the genomic regions of interest 
(Table 2). Culture growth was monitored by measuring the absorbance at 600 nm. 
 
2.2.2. Preparation of cell lysates for ribosomal fractionation 
Isolation of ribosomal species was performed as previously described [21] with 
the following exceptions. Cultures of LB broth were inoculated with 1/200th volume of a 
stationary overnight culture. For strain JM6733 (ΔproQ::KAN) containing the indicated 
plasmids, Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final 
concentration of 15 µM after the first 30 min of incubation to induce the expression from 
the lac promoter. Cell pellets were resuspended in 700 µL of lysis buffer containing 10 
mM Tris pH 7.5, 10 mM MgCl2, and 60 mM NH4Cl per 100 mL of starting culture, flash 
frozen in liquid nitrogen, and stored at -80oC. 300 µm glass beads were added to frozen 
cells as they thawed. Cells were lysed by repeated vortexing for 1 min followed by 1 min 
on ice for a total time of 10 min. The lysate was cleared by centrifugation at 21,000 x g 
for 10 min at 4oC. For subunit dissociation experiments, cells were lysed without 
addition of chloramphenicol, in buffer containing 10 mM Tris pH 7.5, 1 mM MgCl2, and 
60 mM NH4Cl and clarified as described. The absorbances of clarified lysates were 
measured at 260 nm.  
 
2.2.3 MNase digestion of ribosomes 
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Lysates were prepared as previously described. 13 OD260 units of lysate were 
transferred to a clean, 1.5 mL microcentrifuge tube. CaCl2 was added to a final 
concentration of 5 mM. BSA (NEB) was added to a final concentration of 0.1 mg/mL. 4 
µL of MNase (NEB) were added and the final reaction volume was brought up to 400 µL 
with lysis buffer. Digests were carried out at room temperature for 30 min. Mock digests 
were set up as controls, containing all reagents except MNase. 
 
2.2.4. In vitro binding of ProQ and 70S ribosomes 
 70S ribosomes (NEB) were incubated with an equimolar ratio of purified ProQ in 
polysome lysis buffer, with or without equimolar P2 mRNA. Reactions were loaded onto 
sucrose gradients and separated as described. 
 
2.2.5. Ribosomal fractionation 
Ribosomal species were separated on sucrose gradients ranging from 10% to 
47% sucrose in pollyalomar ultracentrifuge tubes (Beckman). Sucrose was dissolved in 
the following buffer: 100 mM NH4Cl, 10 mM Tris pH 7.5, 10 mM MgCl2. 550 µL of 47% 
sucrose was added into the bottom of the tube and placed at -80oC until frozen. Next, 
42% sucrose was added and the tube was placed back at -80oC until frozen. This 
method was repeated until the gradient was complete, using the following 
concentrations of sucrose: 47%, 42%, 37%, 32%, 27%, 22%, 17%, 12%, 10%. 
Gradients were stored at -80oC. Gradients were allowed to thaw completely at room 
temperature. 13 OD260 units of lysate were applied to the top of each gradient. 
Gradients were balanced and submitted to ultracentrifugation in an SW50.1 (Beckman) 
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rotor at 41K RPM for 1.5 h at 4oC. After ultracentrifugation, fractionation was performed 
as previously described [21]. Separation of dissociated subunits was done by 
ultracentrifugation on 20% sucrose cushions in an SW40TI (Beckman) rotor at 23 K 
RPM for 15 h at 4oC. Fractionation was performed as previously described. 
 
2.2.6. Mutant His-ProQ constructs 
Mutant constructs were made using pCA24N-ProQ from the ASKA collection [22] 
as a template for inside-out PCR. A SacI restriction endonuclease site was added to 
both primers (Table 2), allowing linear products from PCR amplification to be digested 
and self-ligated in frame to create pDS1-pDS5 (Table 1). 
  
2.2.7. ProQ purification and antibody production 
A culture of JM6733 (ΔproQ::KAN), transformed with pCA24N-ProQ, was grown 
to late-logarithmic growth phase (OD600 ≈ 0.8) at 37oC in LB media. Production of a 6 
histidine epitope-tagged ProQ was induced by addition of IPTG to a final concentration 
of 1mM, and the culture was shifted to ambient temperature with shaking. Cells were 
harvested 18 h post induction. Cells were resuspended in 8 mL of lysis buffer (10% 
glycerol, 20 mM Tris pH 8.0, 500 mM NaCl, 10 mM Imidazole, and 1 mM β-
Mercaptoethanol) and complete EDTA-free protease inhibitors (Roche) per 1 g of wet 
pellet weight and disrupted by 5 passes through a french press. Insoluble debris was 
cleared via centrifugation at 15,000 RPM for 30 min at 4oC in an SA-600 rotor (Sorvall). 
Nickel affinity chromatography was performed using Ni-NTA Superflow resin (Qiagen) 
as per manufacturer’s directions with the following exceptions. After batch binding of 
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6His-ProQ the column was washed with 5 column volumes (CVs) of lysis buffer. 
Additional 5 CV washes were done with lysis buffer containing 1 M NaCl, as well as 
lysis buffer containing 20 mM and 30 mM Imidazole. 6His-ProQ was eluted from the 
column using 5 CVs of lysis buffer containing 500 mM Imidazole. Protein purity was 
monitored via SDS-PAGE, and the eluent was dialyzed overnight at 4oC in a low-salt 
buffer (10% glycerol, 20 mM Tris pH 8.0, 100 mM NaCl, 1 mM β-Mercaptoethanol). 
Cation exchange chromatography was performed using SP Sepharose Fast Flow resin 
(GE Healthcare). Cation exchange resin was equilibrated with 5 CVs of low salt buffer. 
Dialyzed 6His-ProQ was incubated with equilibrated resin for 30 min at room 
temperature with occasional agitation. After batch binding, the column was washed with 
5 CVs of low salt buffer. 6His-ProQ was eluted from the column using a gradient of 
NaCl (100 mM to 1 M). 6His-ProQ purity was monitored via SDS-PAGE, and purified 
6His-ProQ was again dialyzed against a low-salt buffer. After dialysis, 6His-ProQ was 
concentrated using a centrifugal filter with a 3 kDa molecular weight cutoff (Amicon), as 
per manufacturer’s directions. Purified 6His-ProQ was quantified using an ND-1000 
spectrophotometer (NanoDrop Technologies, Inc.) and 600 µg was sent for antibody 
production in a rabbit host (Cocalico Biologicals, Inc). 
 
2.2.8. Western-blot analysis of ribosomal fractionations 
Denaturing SDS-PAGE loading buffer (50 mM Tris pH 6.8, 2% Sodium dodecyl 
sulfate (SDS), 10% glycerol, 1% β-Mercaptoethanol, 13 mM EDTA, 0.02% 
Bromophenol blue) was added to trichloroacetic acid (TCA) precipitated ribosomal 
fractions. Briefly, TCA was added to polysome gradient fractions to a final concentration 
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of 15% and incubated at 4oC for 30 min. The precipitant was pelleted in a 
microcentrifuge at maximum speed for 10 min. The supernatant was removed and the 
pellet was washed twice with ice cold 100% acetone. Proteins were separated via SDS-
PAGE and transferred to nitrocellulose (GE Water & Process Technologies). Protein 
detection was carried out using antibodies against ProQ (1:5000 in 5% dry milk in PBS 
+ 0.1% Tween20) and ribosomal proteins L3 (1:5000 in same) and S2 (1:5000 in same). 
Antibodies to L3 and S2 were a generous gift from Catherine Squires. 
 
2.2.9. Copy number calculation 
proQ was cloned into vector pMCSG7 as described [23] using DS046 and DS047 
(Table 2) to make pDS6 (Table 1), which adds an N-terminal 6-Histidine epitope tag, 
followed by a TEV cleavage site. ProQ was purified as previously described with the 
following exceptions. After the first nickel affinity column, elution fractions were pooled 
and dialyzed overnight in the presence of 6His-TEV protease. A second nickel affinity 
column was used to remove TEV protease and the flow through was collected. 
Fractions were analyzed via SDS-PAGE and pooled for cation-exchange 
chromatography. Purified ProQ was quantified using a Bradford assay (Biorad). Known 
amounts of ProQ, as well as whole cell lysate from a known number of wild type 
BW25113 E. coli cells were loaded onto SDS-PAGE and transferred to nitrocellulose for 
western-blot analysis using anti-ProQ antibodies. Band intensities were quantified using 
ImageJ and cellular concentration was calculated. 
 
2.2.10. In vitro transcription 
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The proP genomic region was cloned into pBluescriptKS+ in two forms, starting 
at either -182 (proP P1, DS037, DS039) or -95 (proP P2, DS038, DS039). The rpoS 
genomic region was cloned into pBluescriptKS+ (rpoS-T7-forw_SacII, rpoS-T7-rev-PstI). 
PCR was performed to amplify the plasmid DNA for use as an in vitro transcription 
template. The forward primer maintained the integrity of the T7 polymerase dependent 
promoter (pBSIVTforward), and the reverse primer added a stop codon after glycine 
245 for proP P1and P2 (DS076) and after tyrosine 147 for rpoS (rposIVTreverse), 
yielding mRNAs with sizes of 927 bp, 840 bp, and 1041 bp respectively. In vitro 
transcription was carried out as described previously [24], and the mRNAs were 
checked for quality using urea-acrylamide gel electrophoresis and TAE-agarose 
electrophoresis. The mRNA concentrations were determined by electrophoresis on a 
TAE-agarose gel and quantitative comparison to the RiboRuler High Range RNA 
Ladder (Thermo Scientific). 
 
2.2.11. Tryptophan fluorescence 
Purified ProQ was dialyzed into 10% glycerol, 20 mM HEPES pH 7.5, and 100 
mM NaCl. The concentration was determined using Bradford assay. For binding 
experiments, ProQ was diluted to a final concentration of 20 nM in the same buffer plus 
0.005% BRIJ35. Temperature was held constant at 20oC and tryptophan was excited at 
295 nm and fluorescence was monitored at 355 nm using a QuantaMaster4 (Photon 
Technology International). The excitation wavelength was chosen to avoid any possible 
inner-filter effect stemming from the use of nucleic acids as ligands [25]. Increasing 
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amounts of in vitro transcribed mRNAs were added to the reaction and the change in 
fluorescence was observed. 
 
2.2.12. Biofilm assays 
Plasmid pMR20-ProQ was constructed by cloning the amplicon from primers 
DS083 and DS084 into pMR20 [26] cut with KpnI and SacI (Table 2). Biofilm assays 
were performed with modifications of previous protocols [27, 28] as follows. Strains 
were grown overnight in LB + 12.5 µg/mL tetracycline. 30 µL of the saturated overnight 
was inoculated into 1 mL of LB without salt (10 g tryptone, 5 g yeast extract) plus 12.5 
µg/mL tetracycline, in a previously unused borosilicate test tube. Tubes were incubated 
at 25oC without shaking for 6 d. After 6 d, the media and loose cells were removed and 
the OD600 was measured. Tubes were gently rinsed by submerging in deionized water 5 
times and allowed to air dry. Biofilms were stained using 1% crystal violet for 20 min. 
Tubes were again rinsed by submerging in deionized water to reduce background 
staining. Biofilms were resuspended completely in 0.5% SDS and the OD600 was 
measured. Relative biofilm formation was calculated as described previously [27]. 
 
2.3. Results 
2.3.1. ProQ associates with translating ribosomes 
In order to verify the localization of ProQ on ribosomes, the soluble lysates from 
wild type E. coli (strain BW25113) were separated on sucrose density gradients (Figure 
2.1A). Western-blot analysis of the resulting fractions revealed that ProQ predominantly 
associates with 70S and translating ribosomes, and to a lesser extent, at the top of the 
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gradient and in fractions corresponding to the 30S ribosomal subunit. Antibodies against 
small and large ribosomal subunit proteins validated the assignment of the peaks in the 
UV-absorbance trace. Deletion of some ribosome-associated factors can lead to 
ribosomal defects and perturbation of the polysome profile [21]. Profiles from a ΔproQ 
strain were indistinguishable from wild type (data not shown), and therefore, ProQ is not 
likely a ribosome assembly factor, nor is it required for the translation of the majority of 
mRNAs in the cell. 
Since the 30S and 50S ribosomal subunits work in tandem, but with separate 
roles during translation, identifying the subunit with which ProQ associates provides a 
clue as to the function of ProQ during translation. When isolated at lower concentrations 
of Mg2+, 70S ribosomes dissociate into 30S and 50S subunits [29]. At 1 mM Mg2+, the 
70S and polysome species were predominantly dissociated, as revealed by the UV-
absorbance trace and localization of S2 and L3 (Figure 2.1B). A large proportion of 
ProQ was found at the top of the gradient, but ProQ that did migrate into the gradient 
peaked with the 30S subunit but not with the 50S subunit. These data are consistent 
with the localization under non-dissociating conditions (Figure 2.1A). Thus, ProQ 
appears to preferentially associate with the 30S subunit. 
 
2.3.2. The N-terminus and linker regions are necessary for ribosome association 
ProQ is predicted to contain two structural domains, tethered by a positively 
charged linker region. The N- and C-termini have been modeled on the RNA binding 
proteins FinO and Hfq respectively [11, 14]. Using available bioinformatic tools to 
predict secondary structure, disordered regions, and nucleic acid binding propensity 
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[30-32], we assigned the boundaries of the linker region as amino acids E116-V180. 
Assignment of the lower bound was the most difficult. The nucleic acid binding 
predictor, BindN, indicated the presence of an unstructured positively charged domain 
starting at E116. The secondary structure predictor, PSIPRED, indicated the presence 
of an alpha helix until A124. Domain constructs were made using the 6HIS-ProQ 
plasmid from the ASKA collection [22] as a template. A schematic of each construct is 
provided (Figure 2.2A). To determine the regions of ProQ that are necessary for its 
association with the ribosome, each ProQ construct was expressed in a ΔproQ 
background, such that it was the only copy of ProQ in the cell. We could not detect a 
ProQ variant expressing only the C-terminal domain (proQ181-232). The distribution of 
ectopically expressed 6HIS-ProQ (Figure 2.2B) was similar to that of ProQ from wild 
type cells (Figure 2.1A); although, in addition to an association with 70S, polysome, and 
30S fractions, there was a general increase in ProQ throughout the gradient. This 
broader distribution may reflect a higher than normal cellular concentration caused by 
exogenous expression or a decrease in affinity for translating ribosomes due to the N-
terminal 6HIS-epitope tag. The high rate of speed and high G-forces produced during 
polysome fractionation can physically disrupt binding interactions, so addition of the 
epitope tag may cause dissociation of 6HIS-ProQ from ribosomes as it progresses 
through the gradient. Deletion of the C-terminal Hfq domain (proQΔ181C) did not affect 
association with the ribosomes (Figure 2.2B), and therefore, this part of the protein is 
not required for ribosome localization. In contrast, both the N-terminus and linker 
regions are required for ribosome association, as the majority of proQΔ115N and 
proQΔ124-180 were found at the top of the gradient. Consistently, removal of the C-
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terminus and linker domains together (proQ2-123) caused ProQ to be found at the top 
of the gradient. Moreover, the linker domain (proQ116-180) was not sufficient for 
ribosome association. These data suggest that both the N-terminal FinO domain and 
the linker regions are required for ribosome association of ProQ. 
  
2.3.3. ProQ interacts with the mRNA being translated 
The comigration of ProQ into sucrose gradients with translating ribosomes could 
occur because of a physical interaction with the ribosome directly or because of an 
interaction with the mRNA bound by a 30S particle and/or 70S particle. To determine 
the nature of the ProQ association with ribosomes, we partially hydrolyzed the mRNA in 
cell lysates with micrococcal nuclease (MNase) under conditions that did not perturb the 
integrity of the highly structured, and relatively RNase insensitive, ribosome. As 
expected, the small ribosomal protein S2 was found associated with the remaining 70S 
and 2-mers, and no appreciable amount of S2 was found at the top of the gradient. This 
supports the claim that the integrity of these ribosomes was maintained. In mock 
treatments, mRNAs with up to 4 ribosomes are seen in sucrose gradients, and ProQ 
associates with all translating ribosomes (both the 70S and polysome forms) (Figure 
2.3A). After treatment with MNase, the level of total polysomes was decreased 
concomitant with a large increase in free 70S ribosomes (Figure 2.3A) and consistent 
with cleavage of intra-ribosome mRNA. Strikingly, in contrast to a robust association of 
ProQ with 2-mer and 3-mer polysomes in untreated samples, ProQ was almost absent 
from these particles in the MNase treated samples. Additionally, a significant amount of 
ProQ was found at the top of the gradient, consistent with dissociation of ProQ from the 
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ribosomes after disruption of mRNA. Thus, ribosome association of ProQ appears to be 
partially dependent on the mRNA being translated. In order to support this finding, we 
also performed in vitro binding experiments with mRNA-free 70S ribosomes. 70S 
ribosomes were incubated with equimolar purified ProQ, with or without proP P2 mRNA. 
After incubation, the reactions were applied to sucrose gradients and separated as 
before (Figure 2.3B). Though some ProQ is found in the gradient under the 70S peak, 
indicating a weak interaction with 70S ribosomes, the bulk of the ProQ is located in the 
fractions not corresponding to the 70S ribosomes. It is also worth noting that when proP 
mRNA was added, we consistently observed the concentration of ProQ in the gradient 
peaking around fraction 5. The best explanation for this result is that ProQ is binding to 
the proP mRNA and migrating to this region of the gradient. 
 
2.3.4. ProQ does not bind selectively to proP mRNA 
It has been demonstrated that ProQ can bind to a model RNA substrate in vitro 
[14]. However, the model double-stranded substrate used previously was relatively 
small (39 bp in duplex form) compared to the size of an mRNA. To further understand 
the RNA binding properties of ProQ, binding experiments were performed using purified 
ProQ and in vitro transcribed mRNA substrates (Figure 2.4A). One possibility is that 
ProQ acts as a proP mRNA-specific translation factor. If true, we would predict that 
ProQ should interact preferentially with proP mRNA in vitro. We tested the ability of 
ProQ to bind to mRNA made from the proP P1 and P2 promoters, as well as an 
unrelated mRNA, rpoS (see methods). Under the conditions tested, ProQ showed no 
preference for proP mRNA transcribed from promoter P1 or P2, and the binding affinity 
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for proP P1 and P2 were similar (17.0 ± 6.1 nM and 11.6 ± 2.7 nM, respectively; Figure 
2.4). Interestingly, ProQ also bound tightly to rpoS mRNA (19.5 ± 7.8 nM; Figure 2.4). 
These slight differences among the KD values are not sufficient to confer selectivity in 
vivo. Comparisons of our values to those previously reported for the model substrate 
are in agreement [14], though we report consistently lower KD values. ProQ binds non-
selectively to all mRNAs tested, but it does not bind to DNA, and we include the results 
as a negative control. To complement the determination of the KD values for specific 
mRNAs we sought to determine the cellular abundance of ProQ. Using quantitative 
western-blot analysis, we estimate the cellular copy number of ProQ to be 1.90 x 103 ± 
324 (95% confidence interval, data not shown). Assuming a cellular volume of 1.3 µm3 
[33], the cellular concentration of ProQ is 2.43 ± 0.414 µM. This number is comparable 
to another estimate for the ProQ copy number obtained by high-throughput  proteomic 
analysis of E. coli cytosolic proteins [34], and at approximately 2,000 copies/cell, ProQ 
is in the top 25% in terms of protein abundance. 
 
2.3.5. Ribosome association of ProQ is not dependent on proP or proU 
We have shown that ProQ is found on translating ribosomes and this association 
appears to be mediated through mRNA. Because the only well characterized phenotype 
for a proQ mutant is a decrease in proline uptake, we posit that ProQ is involved in the 
translation of a subset of mRNAs in the cell, including one or more of the proline 
transporter mRNAs. We therefore asked whether the ribosome association of ProQ was 
dependent on these mRNA transcripts. We first examined the localization of ProQ in a 
ΔproP mutant, as proP mRNA is the predicted target of ProQ. We found, however, that 
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the ribosome association of ProQ was similar in a ΔproP strain to that seen in the wild 
type strain (Figures 2.1 and 2.5). A genetic interaction has been reported between proQ 
and the proW and proX loci within the proU operon [35] and therefore, these genes may 
be regulated by ProQ. For this reason, we examined ProQ localization in strain 
backgrounds deleted for each member of the proU operon, as well as a deletion of the 
entire proU operon (proVWX), and deletion of both proVWX and proP together. In all 
backgrounds tested, ProQ is repeatedly found associated with 70S particles and 
polysomes (Figure 2.5). Thus, ProQ ribosome association is not absolutely dependent 
on any of these genes, and the ribosome association of ProQ may be due to one or 
more additional cellular mRNAs.  
 
2.3.6. ProQ is necessary for biofilm formation, independent of ProP 
Having shown that ProQ localization to the ribosome is independent of all known 
potential interactions involved in proline transport, we sought to expand the ProQ target 
list by looking for new ΔproQ phenotypes. A high throughput study implicated ProQ in 
biofilm formation; though, it only reported it as a hit and did not verify the result through 
plasmid-based complementation [27]. Under the conditions tested, a proQ mutant strain 
was found to be about 50% deficient in biofilm formation compared to wild type cells 
(Figure 2.6). This phenotype was complemented by transforming ΔproQ cells with a 
low-copy plasmid containing the proQ gene, plus 500 bp of sequence upstream of the 
translation start site. To test if this phenotype was independent of the role of ProQ in 
ProP regulation, we examined biofilm formation in a proP mutant strain. This strain was 
able to form biofilms as well as wild type. As a result, we conclude that the decrease in 
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biofilm formation is unique to a proQ mutant and is independent of the ProQ-ProP 
interaction, though the reason for this deficiency remains unclear.  
 
2.4. Discussion 
It has been proposed that ProQ is a translational regulator of proP mRNA [14]. 
This hypothesis has evolved and emerged out of a sort of “process of elimination”, 
whereby it has been shown that i) proP transcript levels are unchanged in a proQ 
mutant [10] ii) no physical interaction can be detected between ProQ and ProP [35], and 
recently iii) ProP expression levels are affected by deletion of proQ [14]. In this study, 
we present the first direct evidence of a ProQ-translation link by demonstrating the 
association of ProQ with 70S particles, translating ribosomes, and 30S particles (Figure 
2.1), but we have not detected a specific interaction between ProQ and proP mRNA at 
the ribosome. Some proteins that associate with the ribosome are involved in ribosome 
maturation and assembly [21, 36]. Deletion of these factors can result in defects in 
polysome profiles and decreased growth rates [for reviews see [37]]. These phenotypes 
are not observed in a proQ mutant (data not shown), and because of the relative dearth 
of phenotypes associated with a proQ deletion, it is unlikely that ProQ is an assembly 
factor. Thus far, ProQ has only been implicated in proline uptake [10] and stimulation of 
biofilm formation [[27] and this study]. For these reasons, we propose that ProQ has a 
very narrowly defined role in the translation of only a subset of mRNAs. This hypothesis 
is bolstered by the fact that the N-terminus of ProQ has been modeled on FinO, a highly 
specified translational regulator, which acts to specifically represses the translation of 
traJ mRNA by facilitating the interaction between traJ and the anti-sense RNA finP [38, 
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39]. As for the identities of the specific mRNA targets of ProQ, proP remains a favored 
target, but it is unknown if this effect is direct or indirect. Additionally, one or more 
additional targets are predicted to exist, based on the ProP-independent biofilm defect 
in a proQ mutant. 
It had previously been shown that ProQ could bind to a model RNA, and that 
ProQ exhibits RNA chaperone-like activity [14]. Here we sought to explore the 
interaction between ProQ and RNA in three distinct ways. First, we examined the 
consequences of nuclease treatment on the association of ProQ with the ribosome 
(Figure 2.3A). Limited treatment of lysates with MNase caused a decrease in the 
number of polysomes observed after centrifugation. Specifically, the number of 3-mers 
and higher molecular weight species were significantly decreased. The loss of 3-mers is 
consistent with the increase in the number of 70S ribosomes observed. Though 3-mers 
were almost completely missing, a significant amount of ribosomes were still found to 
exist as 2-mers. MNase treatment had a large effect on the localization of ProQ, 
however, causing it to almost completely delocalize from 2-mers and 70S ribosomes. To 
further explore the requirement of mRNA for ProQ-ribosome association, we examined 
the ability of ProQ to bind to mRNA-free ribosomes in vitro. Not surprisingly, ProQ did 
not robustly associate with these ribosomes, and instead, seemed to prefer to bind to 
mRNA when present in the reactions (Figure 2.3B). For these reasons, we conclude 
that the mRNA being translated is very important for the comigration of ProQ with 70S 
and polysome species. Next, we used a quantitative in vitro binding assay to determine 
the affinity of ProQ for its predicted mRNA target, proP (Figure 2.5). The hypothesis that 
ProQ enhances proP translation, to the exclusion of other mRNAs, leads to the 
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prediction that ProQ should selectively recognize proP. Under the conditions tested, 
ProQ binds tightly to proP mRNAs, but this binding is not selective, as ProQ binds with 
similar affinity to rpoS mRNA (Figure 2.4). Though we cannot rule out the possibility that 
rpoS is also a target of ProQ regulation we believe this is unlikely since RpoS is a 
known regulator of proP transcription [7, 40],  proP transcript levels are unchanged in a 
ProQ mutant [10], and a proQ deletion strain does not have the same lack of 
thermotolerance seen in an rpoS deletion strain [14].  If proP is a direct target of ProQ, 
some other factor must confer specificity in vivo.  
Little is known about ProQ, mechanistically. Previous studies have shown that 
exogenous expression of the N-terminal, FinO-like domain (residues 1-130) can partially 
complement the proline uptake deficiency of a proQ chromosomal deletion, and the N-
terminus (1-130) is necessary and sufficient for binding to RNA [12, 14]. Our study of 
the domains of ProQ involved in ribosome association is not entirely consistent with 
these previous results. For example, even though the first 130 residues could bind to a 
model RNA, we do not observe ribosome association of a similar construct to any 
appreciable degree (Figure 2.2B). In this study, we expand the linker by seven residues 
to include amino acids 124-180, thus shortening the N-terminal domain from 1-130 to 1-
123 (Figure 2.2A). This difference could account for the lack of ribosome association if 
residues 124-130 are necessary for RNA binding. Another inconsistency is observed 
with the C-terminus. In this study we find that a construct lacking residues 181-232 is 
associated with the ribosome in a manner comparable to plasmid-expressed wild type 
ProQ (Figure 2.2B). However, in previous studies, this construct did not suppress the 
proline uptake deficiency as well as a construct containing the C-terminal domain [12]. It 
43 
 
must be noted that our present study sought only to identify the domains of ProQ which 
are important for ribosome association, independent of proQ-proP genetic interactions. 
Based on our results, we conclude that only the C-terminus is dispensable for ribosome 
association. Though we would predict that ribosome association is necessary for 
suppression of the proline uptake phenotype, we do not observe a direct dependence. 
This further complicates the mechanism by which ProQ enhances proline uptake. 
A deeper exploration of the mechanism of ProQ action will be predicated on the 
discovery of direct mRNA targets. To date, finding these targets has been challenging. 
To begin the process, here we verified that ProQ is involved in promoting biofilm 
formation [27]. More importantly, we show that this phenotype is independent of ProP, 
yielding the first ProP-independent ProQ phenotype (Figure 2.6). Further independence 
of ProQ from ProP is demonstrated by the fact that ProQ is still associated with 
ribosomes in the absence of proP and proU mRNAs (Figure 2.5). 
Though further studies are needed to definitively determine the function of the 
ribosomal association of ProQ, it is not unreasonable to propose a role for ProQ in 
translation initiation. Under non-dissociating conditions, we observe the highest 
concentration of ProQ in fractions corresponding to 70S and polysome species, but 
there is a modest, yet consistent, increase in signal under the peak corresponding to 
30S particles, the first particle to bind during initiation (Figure 2.1A). This 30S 
localization is confirmed under dissociating conditions (Figure 2.1B). We present data 
showing that ProQ can bind tightly to mRNA in vitro (Figure 2.4), and mRNA integrity is 
necessary for robust ribosome association (Figure 2.3). Thus, ProQ is ideally positioned 
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to function in translation initiation of its mRNA targets, perhaps by facilitating the 
interaction between 30S particles and these as-yet unidentified mRNAs. 
 
2.5. Update 
Since publication of this chapter, a paper has been published which 
demonstrates that the stability of proP mRNA and the level of ProP protein in the cell is 
controlled by the riboendonuclease RNase III [41]. In RNase III deficient cells, the half-
life of proP is increased, and the protein levels, likewise, increase (Figure 2.7). As 
noted, proP mRNA is transcribed from two different promoters, a distal promoter called 
P1 and a proximal promoter, P2. Because the effects of ProQ deletion on ProP protein 
levels were reported to be dependent upon growth phase and osmolarity of the media, I 
had originally predicted that ProQ might affect the translation of one proP mRNA, while 
having little effect on the other. As P1 is the osmotically responsive promoter, I 
hypothesized that ProQ might bind more tightly to, and therefore regulate the translation 
of, proP P1 mRNA. Interestingly, the paper referenced above finds that only the P1 
transcript is affected by RNase III. This arises from the RNase III recognition and 
cleavage site being positioned upstream of the P2 promoter (Figure 2.8).  
Discovery of this fact made it necessary to reexamine whether choosing rpoS 
mRNA as a negative control for my in vitro ProQ-mRNA binding experiments was valid, 
as rpoS levels are regulated by RNase III [42]. Even though it was reported that proQ 
mutant strains do not exhibit phenotypes similar to that of rpoS-deficient cells, it is 
possible that, like its reported control of proP translation, the effects of ProQ on rpoS 
translation might be subtle and nuanced. This experiment should be replicated using an 
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mRNA not regulated by RNase III; though, the ability of ProQ to bind to proP P2 mRNA 
in this assay still suggests that binding to mRNA is not selective under the conditions 
tested.  
In light of both of these data, I examined the RNase III regulatome more closely.  
In this chapter, I show that deletions of proQ have an effect on biofilm formation, 
causing about a 50% decrease in formation (Figure 2.6). Formation of robust biofilms is 
dependent upon many factors, but one factor which is positively correlated with biofilm 
formation is the E. coli flagella. The main protein component of the flagella is FliC, and 
preliminary data I obtained shows that FliC expression is almost completely abolished in 
ΔproQ strain (Figure 2.9). More evidence of a ProQ-RNase III link comes from the fact 
that fliC mRNA levels are also regulated by RNase III. Again, fliC mRNA levels are 
much higher in an RNase III mutant than they are in wild type. Oddly, attempts to 
complement the loss of FliC expression in ΔproQ strains by expression of ProQ from a 
plasmid were unsuccessful (Figure 2.10). It is unclear what consequence this has on 
the hypothesis that fliC might be a target for regulation by ProQ. However, personal 
communications with labs studying the mRNAs associated with ProQ strengthen the 
connection between FliC and ProQ.  
Taken together, there is a “preponderance of evidence” linking RNase III and 
ProQ. In the cases of proP P1 and fliC mRNAs, loss of RNase III stabilizes the mRNAs, 
while loss of ProQ results in a decrease in protein levels. The effects of ProQ on rpoS 
are not currently known, but should be examined. It seems that ProQ and RNase III are 
functioning semi-redundantly to upregulate translation, RNase III by increasing 
messenger stability, and ProQ by enhancing translation through some unknown 
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mechanism. It is possible that deletion of proQ might abolish the increase in proline 
uptake by ProP observed in an RNase III mutant strain. To extend it further, an RNase 
III mutant might suppress the biofilm defect in a proQ mutant and restore FliC levels to 
that of wild type cells. Further discussion is presented in Chapter V of this document. 
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Figure 2.1. Ribosome association of ProQ under native and dissociating 
conditions. Polysome profiles (254 nm) from wild type cell extracts in (A) associating 
conditions (10 mM Mg2+) and (B) dissociating conditions (1 mM Mg2+) are shown. 
Western-blot analysis of TCA-precipitated fractions using antibodies to ProQ, small 
ribosomal subunit protein 2 (S2), and large ribosomal subunit protein 3 (L3) are shown 
and aligned to the UV-absorbance trace. Whole cell extracts from wild type (BW25113) 
and ΔproQ (JM6733) are included, as is the soluble lysate (Load). UV-absorbance 
peaks correspond to (L to R): Free RNA/protein, 30S, 50S, 70S, and polysomes. 
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Figure 2.2. Ribosome association of plasmid encoded proQ mutant constructs in 
polysome profiles. (A) Schematic representation of proQ mutant constructs expressed 
from the IPTG inducible plasmid pCA24N. The predicted RNA binding region is colored 
in black, and amino-acid boundaries of each construct are labeled. (B) Mutant 
constructs were expressed as the lone copy of proQ. Western-blot analysis of TCA-
precipitated fractions from the separation of ribosomal moieties on sucrose density 
gradients was performed. Whole cell extracts of cells after induction were included 
(Induced) along with soluble lysate (Load). Position of the 30S, 50S, 70S, and 
Polysome species are indicated based on western-blot localization of S2 (data not 
shown). 
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Figure 2.3. Robust 70S ribosome association of ProQ requires intact mRNA. (A) 
Cell lysates were left untreated (solid line) or treated with limited MNase (dashed line) 
and ribosomal species separated on sucrose gradients. The positions of ProQ and 
ribosomal protein S2 in the resulting TCA-precipitated fractions is determined by 
western-blot analysis. (B) mRNA free 70S ribosomes were mixed with equimolar 
amounts of purified ProQ without (foreground) or with (background) the addition of 
equimolar P2 mRNA before application to sucrose gradients. The position of ProQ and 
ribosomal protein S2 in the resulting TCA-precipitated fraction is determined by 
western-blot analysis.  
 
 
  
50 
 
Figure 2.4. mRNA binding kinetics monitored by native tryptophan fluorescence. 
(A) 20 nM ProQ was titrated with increasing amounts of in vitro transcribed mRNAs (“▲” 
proP P1, “●” proP P2, “■” rpoS). Tryptophan was excited at 295 nm and the 
fluorescence was monitored at 355 nm. The y-axis is provided in terms of normalized 
fluorescence (FLF/FLI), determined by dividing the fluorescence at each mRNA 
concentration (FLF) by the fluorescence for 20nM protein only (FLI). DNA yielded no 
measurable fluorescence shift and is included as a negative control (“□” DNA) (B) 
Summary of binding affinities of ProQ for in vitro transcribed mRNAs.  
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Figure 2.5. Ribosome association of ProQ in various strain backgrounds. Cell 
lysates from various mutant backgrounds, as indicated, were separated by sucrose 
density ultracentrifugation and the localization of the ribosomal species (30S, 50S, 70s, 
polysomes) indicated. The localization of ProQ in the TCA-precipitated fractions is 
shown by immunoblot. Whole cell extracts from wild type, ΔproQ (JM6733), and the 
soluble lysate (Load) are included as indicated. 
 
 
  
52 
 
Figure 2.6. Biofilm formation defect in a ΔproQ strain. Wild type (BW25113), ΔproQ 
(JM6733), and ΔproP (JM6753) strains were examined for formation of biofilms after 6 
days. Strains were transformed with either empty vector (pMR20; shaded) or vector 
containing the proQ open reading frame, plus 500 bp of genomic sequence upstream of 
the translation start site (pMR20-ProQ; unshaded). Error bars represent 95% 
confidence intervals. A statistical difference is indicated (*) between wild type and 
ΔproQ (JM6733) with a p-value < 0.001. 
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Figure 2.7. Changes in proP mRNA and protein levels in response to RNase III 
deletion. (A) Semi-quantitative RT-PCR of proP mRNA in either wild type or RNase III 
null backgrounds (rnc). (B) ProP protein levels in wild type and rnc backgrounds. [41]. 
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Figure 2.8. Location of the RNase III cleavage site with respect to P1 and P2. The 
RNase III cleavage site is in a hairpin which resides upstream of the P2 promoter. [41]. 
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Figure 2.9. ΔproQ cells lack appreciable FliC protein. Western blot analysis of whole 
cell extracts from wild type or ΔproQ strains at 37oC and the indicated culture densities. 
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Figure 2.10. Attempted complementation of the ΔproQ dependent loss of FliC. 
Western blot analysis of FliC levels in wild type, ΔproQ, and pProQ complemented 
strains. 
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Table 2.1: Strains and Plasmids 
Strain  Genotype Origin  
BW25113  ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), lambda-, 
rph-1, ∆(rhaD-rhaB)568, hsdR514  
[19] 
JM6733  BW25113, ΔproQ::KAN  [18], This study  
JM6753  BW25113, ΔproP::KAN  [18], This study  
JM6754  BW25113, ΔproV::KAN  [18], This study  
JM6755  BW25113, ΔproW::KAN  [18], This study  
JM6877  BW25113, ΔproX:KAN  [18], This study  
JM6881  BW25113, ΔproVWX::KAN  This study  
JM6906  BW25113, ΔproP::FRT  This study  
JM6926  BW25113, ΔproP::FRT, ΔproVWX::KAN  This study  
   
Plasmid  Description  Origin  
 pCA24N-ProQ  [22] 
pDS1  pCA24N-ProQΔ115N  This study  
pDS2  pCA24N-ProQΔ181C This study  
pDS3  pCA24N-ProQΔ124-180 This study  
pDS4  pCA24N-ProQ116-180  This study  
pDS5  pCA24N-ProQ2-123  This study  
pDS6  pMCSG7-ProQ  [23], This study  
pMR20 pMR20 empty vector [26] 
pMR20-
ProQ 
pMR20 containing proQ ORF plus 500 bp 
upstream 
This study 
pCP20 Flip Recombinase containing vector [20] 
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Table 2.2: Oligonucleotide sequences  
Name  Sequence (5’ - 3’)  Function  
DS001 GAT CGA GCT CTC TGA CAT TTC AGC TCT 
GAC T  
Construction of 
proQΔ124-180  
DS002 GAT CGA GCT CTT CGC GTT TTT TCG CTT 
GCT G  
Construction of 
proQΔ124-180 and 
proQ1-123  
DS003 GAT CGA GCT CCC CCT ATG CGG CCG CTA A  Construction of 
proQΔ181C and  
proQ1-123  
DS004 GAT CGA GCT CAA CCG GGG TGT GCT GTT C  Construction of 
proQΔ181C  
DS005 GAT CGA GCT CGA ACA GCA AGC GAA AAA 
ACG C  
Construction of 
proQΔ115N and 
proQ181-232  
DS006 GAT CGA GCT CCC TCA GGG CCG GAT CCG T  Construction of 
proQΔ115N and 
proQ181-232  
DS007 GAT CGG TAC CCC CCT ATG CGG CCG CTA A  Construction of 
proQ116-180  
DS008 GAT CGG TAC CAA CCG GGG TGT GCT GTT C  Construction of 
proQ116-180  
DS037 GAT CGA GCT CGT CAT TAA CTG CCC AAT TCA 
GGC GTC  
pBluescript-proPp1  
DS038 GAT CGA GCT CAG AGA TTG CAT CCT GCA ATT 
CCC G  
pBluescript-proPp2  
DS039 GAT CGG TAC CTT ATT CAT CAA TTC GCG GAT 
GTT GCT GC  
pBluescript-proP 
reverse  
rpoS-T7-forw-
SacII  
CCG CGG CCG ACA ATT ACG TAT TCT GA  pBluescript-rpoS  
rpoS-T7-rev-PstI  CTG CAG TTG AGA CTG GCC TTT CTG AC  pBluescript-rpoS  
DS046 TAC TTC CAA TCC AAT GCC ATG GAA AAT 
CAA CCT AAG TTG  
Construction of 6His-
TEV-ProQ  
DS047 TTA TCC ACT TCC AAT GTT ATC AGA ACA CCA 
GGT GTT CTGC  
Construction of 6His-
TEV-ProQ  
DS048 CGC AGG ATA ATC AAC GGA TAA CG  proQ genotyping  
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DS049 ATT TGA TCA GCA CGC GTG ATA TC  proQ genotyping  
DS054 CAG AGA TTG CAT CCT GCA ATT CCC  proP genotyping  
DS055 CCT GAT AAG ACA GCG TCA CAT CAG  proP genotyping  
DS056 GCT CGC ATC AAT ATT CAT GCC ACA  proV genotyping  
DS057 GTA CTG GTC AGC CAG TCA GCA  proV genotyping  
DS058 TAG CGA GTT GCT CTC TCA TGT CG  proW genotyping  
DS059 AGT TTG TGT AGA GAT AAG CGT GGC  proW genotyping  
DS060 GGC CCT GTT GGT CTG CTG AC  proX genotyping  
DS061 GTC GCA TCA GGC ATT GTG CAC  proX genotyping  
DS062 GGT TTC TGG CTG CCG ATG TAT  proVWX (proU) 
genotyping  
DS063 CAG CCT ACA CCC TGC TGC GGG TAG TGA 
TAT  
proVWX (proU) 
genotyping  
DS076 GAT CTC ACT AGC CAT CCT GCA AAC CTT 
CAC G  
proP in vitro 
transcription 
template  
DS077 ATT GGG TAA TAT ATC GAC ATA GAC AAA TAA 
AGG AAT CTT TCT ATT GCA TGG TGT AGG 
CTG GAG CTG CTT CG  
proVWX (proU) 
deletion  
DS078 CAA AAA CGC CTT ATC CGC CCG AAT AAA 
AAT TAC TTC TGC GCT GCC AGC GCC ATA 
TGA ATA TCC TCC TTA G  
proVWX (proU) 
deletion  
DS083 GAT CGA GCT CGT GCG TTG TTA TAT GAG 
CGT C 
Construction of 
pMR20-ProQ 
DS084 GAT CGG TAC CTC AGA ACA CCA GGT GTT 
CTG C 
Construction of 
pMR20-ProQ 
pBSIVTforward CGT TGT AAA ACG ACG GCC AGT G  proP and rpoS in 
vitro transcription 
template  
rpoSIVTreverse  GAT CTC ATT AGG TTG CGT ATG TTG AG  rpoS in vitro 
transcription 
template  
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Chapter III 
Coordinating the sensing of and response to nutrient availability in 
Saccharomyces cerevisiae 
 
 
3.1. Consequences of nitrogen and glucose stresses 
 Essential to the survival of any organism is its ability to respond to changes in the 
nutrient availability presented to it by its environment. During times of nutrient excess, 
yeast cells rapidly grow and divide, doubling in population approximately every 90 
minutes [1]. As the population grows, it eventually consumes the available nutrients, 
and the growth rate slows down or stops. As with everything, the process is more 
nuanced, and yeast can shift from fermenting glucose to oxidizing the ethanol produced 
during that fermentation, a phase of growth known as the diauxic shift [2]. For the sake 
of discussion, nutrient excess will be defined as growth in liquid culture or on solid 
media containing sufficient sources of available carbon (most often glucose) and 
nitrogen, and growth under these conditions will be referred to as “vegetative growth”. 
Limiting nitrogen, glucose, or both, can cause dramatic phenotypic changes. Here, I will 
discuss two such events and some of the processes governing them.  
 
3.1.1. Pseudohyphal growth 
 During conditions where nitrogen is scarce, some strains of Saccharomyces 
cerevisiae are able to switch from vegetative growth to a growth morphology termed 
filamentous or pseudohyphal growth (PHG) (Figure 3.1 [3]) due to its similarities to the
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 hyphal growth of other fungi. During PHG, cells elongate and bud in a unipolar fashion. 
In addition, daughter cells remain physically attached after division. The result is a chain 
of cells [4], and this physical change can be seen by simple light microscopy of 
colonies, as the changed PHG morphology causes perturbation of the normally smooth 
colony edges (Figure 3.2). It is thought that this gross change in cell morphology acts as 
a scavenging mechanism, allowing the non-motile yeast to explore the surrounding area 
for nutrients [5]. It is useful to note two additional points. First, most common laboratory 
strains of S. cerevisiae do not undergo this change to PGH at least partially because of 
a non-functional version of the FLO8 gene, a transcription factor essential to the 
process [6]. Second, surface-spread filamentation (Figure 3.2) is most readily observed 
under conditions of nitrogen stress in diploid cells. 
 
3.1.2. Formation of cytoplasmic mRNP granules 
 A second response to nutrient stress is the formation of cytoplasmic aggregates 
of mRNA and proteins called messenger ribonucleoprotein (mRNP) granules. The exact 
dynamics and composition of these granules varies depending upon induction 
conditions, but this discussion will focus on what is known about mRNP granule 
formation in response to glucose stress [7]. These structures are generally classified 
into two different categories: processing bodies (P-bodies) and stress granules (For 
review see [8]). 
 In general, stress granules are comprised of mRNAs which have been stalled at 
the level of translation initiation and proteins important for that process, including 
translation initiation factors and ribosomal species. These granules are considered to be 
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a sort of “storage site” for components which will be translated after the glucose stress 
has been cleared [9]. P-bodies tend to accumulate mRNAs and protein decay 
machinery. This led to the belief that they are the sites of mRNA turnover, but formation 
of P-bodies is not necessary for mRNA turnover on a global scale [10, 11], and their 
exact purpose is less well understood. Whatever their ultimate purpose, both P-bodies 
and stress granules play an important role in cellular survival and adaptation to stress, 
as numerous studies implicate the proper regulation of their formation and clearance in 
disease (For review see [12]). 
  
3.2. Nutrient responsive pathways in PHG and mRNP formation 
 Chapter IV of this document focuses on the role of one particular protein in the 
regulation of both PHG and mRNP formation. Ksp1p is a kinase whose signaling activity 
is necessary for the switch from vegetative to pseudohyphal growth and for proper 
mRNP granule dynamics, but before looking at Ksp1p specifically, it is important to 
develop the wider context of signal transduction in yeast and how PHG and mRNP 
granule formation are regulated by other known signaling pathways. In Saccharomyces 
cerevisiae, many pathways exist to gather information from outside of the cell and turn 
that information into an appropriate response. These pathways are complex and often 
converge and diverge along the way. For example, it is an over simplification to say that 
glucose levels have no effect on whether or not a cell chooses to switch from vegetative 
to pseudohyphal growth, and vice versa. What follows is a brief introduction into the 
signals coordinated by four different pathways, and ultimately, an overview of how these 
pathways affect the switch to PHG and the formation of mRNPs. 
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 3.2.1. The cAMP/PKA pathway 
 In Saccharomyces cerevisiae, PKA, in its inactive form, exists as a 
heterotetrameric protein comprised of two copies of the regulatory subunit Bcy1p and 
two copies of a catalytic subunit, Tpk [13, 14]. There are three different Tpk subunits, 
not surprisingly called Tpk1p, Tpk2p, and Tpk3p [14]. These subunits are semi-
redundant, but they do appear to differentially regulate pseudohyphal growth, as will be 
discussed later. When the membrane bound G-protein coupled receptor (GPCR), Gpr1, 
senses glucose, it releases the G-protein, Gpa2p [15]. Gpa2p works with the adenylate 
cyclase Cyr1 to stimulate the conversion of ATP into the second messenger cyclic AMP 
(cAMP) [16]. Once formed, cAMP can bind to Bcy1p. This binding of cAMP to the 
regulatory subunits of PKA causes the dissociation of the catalytic subunits. Once 
liberated, the catalytic subunits can influence transcription of genes involved in glucose 
metabolism and stress responses (Figure 3.3 [17]). In addition to Gpr1/Gpa2, Cyr1p 
activity is regulated by the GTPases Ras1p and Ras2p, which also interact with Cyr1p 
to increase cellular levels of cAMP (Figure 3.3 [4]).  
 How the cAMP/PKA pathway responds to nitrogen is not well understood. A 
study of the transcription pattern of cells starved for glucose or nitrogen yielded a 
correlation value just below 0.8, suggesting overlap between glucose and nitrogen 
responsive pathways. More interestingly, the same study demonstrated that after 
adding back the depleted nutrient, recovery was cAMP dependent, and both nitrogen 
and glucose addition inhibited stress responsive genes (Figure 3.3 [18]). 
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3.2.1.1. The cAMP/PKA pathway in pseudohyphal growth 
 The regulation of pseudohyphal growth by PKA is dependent upon the 
accumulation of cAMP. Overexpression of the phosphodiesterase Pde2p, which 
converts cAMP into AMP causes the loss of PHG [4, 19]. As mentioned, binding of 
cAMP to Bcy1p causes the release of the Tpk subunits of PKA. Depending upon the 
Tpk subunit which is activated, PHG is differentially affected. Tpk2p has the most 
straightforward effect on PHG. To stimulate filament formation, Tpk2p phosphorylates 
the transcription factor Flo8p which, in turn, enhances transcription of the major 
flocculence gene, FLO11 [20]. Deletion of Tpk3 causes cells to be hyperfilamentous, 
suggesting that Tpk3p is a negative regulator of PHG. Tpk1p acts more indirectly to 
regulate the kinase Yak1p via phosphorylation. Phosphorylation of Yak1p inactivates it. 
Yak1p transduces its signal through two transcription factors, Sok2p and Phd1p, which 
also regulate FLO11 transcription (Figure 3.3 [20-22]). 
 
3.2.1.2. The cAMP/PKA pathway in mRNP regulation 
 Several studies have been conducted looking at the localization of the Tpk 
subunits of PKA during conditions which induce mRNP formation and the role of PKA 
signaling on mRNP formation. What has been found is that both Tpk2p and Tpk3p can 
localize to P-bodies (Figure 3.3 [23]), constitutive activation of the PKA pathway in a 
specific ras2p mutant background blocks P-body formation, and overexpression of any 
of the catalytic subunits of PKA also inhibits P-body formation, likely by phosphorylating 
the P-body associated protein Pat1 [24]. PKA appears to play less of a role in the 
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regulation of stress granule formation, but in light of our study presented in Chapter IV, 
this may be dependent upon induction conditions.  
 
3.2.2. The MAPK pathways 
 Saccharomyces cerevisiae have five well characterized mitogen-activated protein 
kinase (MAPK) pathways. In general, a signal is received by a receptor protein at the 
cell surface, and a signal is transduced via a triplet of kinases, a MAPKKK (or MAP3K), 
a MAPKK (MAP2K), and finally the MAPK [25]. The MAPK in turn regulates 
transcription factors via phosphorylation to generate a cellular response appropriate to 
the signal. The pathways regulated and their respective MAPKs are as follows: 
sporulation via Smk1p [26], cell wall integrity via Slt2p [27], osmotic balance via Hog1p 
[28], mating and pheromone response via Fus3p [29], and filamentation via Kss1p [30]. 
 At first glance, MAPK pathways appear fairly linear (Figure 3.4 [31]). Upon closer 
examination it can be seen that many components are shared among the pathways, 
especially among the mating, filamentation, and osmo-responsive pathways. Upstream 
of the MAPKKK, Ste20p is involved in regulation of all three pathways. The MAPKKK 
Ste11p is also shared among these MAPK cascades (Figure 3.4). It seems likely that a 
particular stimulus may have unintended consequences, by increasing signaling through 
overlapping pathways, but inter-pathway inhibition by specific proteins helps to prevent 
this. That said, these interdependencies serve to add complexity to the MAPK pathways 
([32] and for review see [33]). 
 
3.2.2.1 The MAPK pathway in pseudohyphal growth 
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 As mentioned above, pseudohyphal growth is stimulated by nutrient limiting 
conditions, allowing cells to forage for nutrients in the surrounding areas. Low nitrogen 
conditions have been traditionally used to examine PHG, but glucose limitation can also 
stimulate PHG [34]. The MAPK pathway is capable of responding to both nitrogen and 
glucose levels. At the membrane, nutrient limitation is sensed by three proteins: Msb2p, 
Sho1p, and Opy2p. Once sensed, the GEF Cdc24p and GTPase Cdc42p activate 
Ste20p. Phosphorylation of the MAPKKK Ste11p by Ste20p eventually leads to 
activation of the transcription factors Ste12p and Tec1p by the MAPK Kss1p. Once 
activated Ste12p and Tec1p bind upstream of the FLO11 promoter and stimulate 
transcription [35] (Figure 3.4). 
 
3.2.2.2. The MAPK pathway in mRNP regulation 
 The role of the MAPK pathways in mRNP formation is not well characterized, but 
there are a few proteins involved in MAPK signaling which do play a regulatory role in 
granule formation or dynamics. Ste20p is one such protein. It has been shown that 
Ste20p phosphorylates the P-body protein Dcp2p, and this phosphorylation event is 
important for Dcp2p localization to P-bodies. Also, failure of Dcp2p to localize to P-
bodies results in aberrant stress granule formation [36]. Also, in a screen for mRNA 
binding proteins whose localization becomes punctate in low glucose stress, Ste20p 
was occasionally, though not consistently found to form puncta (Figure 3.4 [37]). This is 
consistent with our results, presented in Chapter IV.  
 
3.2.3. The SNF1 pathway 
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 SNF1 is a heterotrimeric complex comprised of the catalytic alpha subunit Snf1p, 
the gamma subunit Snf4, which serves a regulatory function, and one of three beta 
subunits: Sip1p, Sip2p, or Gal83p [38]. The name SNF1 stands for Sucrose 
NonFermenting as SNF genes were originally identified in mutants unable to grow on 
sucrose as a carbon source [39]. When glucose is limiting, SNF1 is phosphorylated on 
the Snf1p subunit by one of three upstream kinases: Sak1p, Elm1p, or Tos3p [40-42]. 
Upon activation, the cellular localization of the Snf1p complex shifts from cytoplasmic to 
nuclear, and the complex can act to activate glucose-repressed genes (Figure 3.7 [43]).  
 Inactivation of SNF1 occurs when glucose is present. To achieve inactivation, the 
phosphatase, PP1, dephosphorylates threonine 210 which is phosphorylated by the 
upstream activating kinases. PP1 is comprised of two proteins Reg1p and Glc7p. It is 
the Glc7p subunit of PP1 which is responsible for the dephosphorylation and 
inactivation of SNF1 [44, 45]. 
 
3.2.3.1. The SNF1 pathway in pseudohyphal growth 
 The regulation of PHG by SNF1 is complicated by the fact that the conditions 
needed to induce SNF1-dependent PHG seem to differ between haploids and diploids. 
Haploid strains are not able to undergo surface spread filamentation, but they are able 
to invade agar. When glucose is depleted in haploid cells, Snf1p represses two FLO11 
transcriptional repressors Nrg1p and Nrg2p. Haploid cells expressing Flo11p are able to 
invade the solid agar surface (Figure 3.6) [46, 47]. SNF1 diploid mutants grown on low 
nitrogen media were also deficient for PHG, and deletion of nrg1 and nrg2 suppress the 
defect, again placing them in the same pathway, but this time responding to nitrogen 
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stress (Figure 3.5 [47]). Upstream of SNF1, the kinase Elm1p also acts as a regulator of 
PHG. Deletion of Elm1p causes strains to become hyperfilamentous, so Elm1p acts as 
a negative regulator of PHG through a SNF1-independent pathway [48]. 
 
3.2.3.2. The SNF1 pathway in mRNP regulation 
 Formation of mRNPs is a response to glucose limitation, so it seems obvious that 
the glucose sensing SNF1 pathway would be involved. However, it has been shown that 
defects in the Snf1p kinase do not alter P-body formation [24]. There is evidence to 
suggest that Snf1p might be involved in localizing some proteins to stress granules, 
however. Snf1p has been shown to directly phosphorylate the kinase Psk1p both in vitro 
and in vivo. This activates Psk1p to phosphorylate the known stress granule associated 
protein Pbp1p. Pbp1p has been shown to recruit the growth regulating TOR complex 
(discussed in more detail below) to stress granules [49]. Circumstantial evidence 
suggests that phosphorylation of Pbp1p by Psk1p may activate Pbp1p to accomplish 
this sequestration when nutrients are limited (Figure 3.5 [50]). 
 
3.2.4. The TOR pathway 
 The Target of Rapamycin (TOR) pathway is named for its central kinase, the 
TOR kinase. TOR kinase is part of a multisubunit complex. In yeast there are two 
different TOR kinases, TOR1 and TOR2, which means that two distinct complexes 
exist, namely TORC1 and TORC2, but TORC1 may contain either TOR1 or TOR2. The 
differentiation comes from the other proteins in the complex (For review see [51]). 
Unless otherwise noted, this discussion will focus on TORC1. At its heart, the TOR 
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complex senses the nutrient availability and stimulates growth when nutrients are not 
limiting. When stresses are present, the complex is inactivated, arresting growth until 
the stress has passed [51]. 
 Processes regulated by TORC1 are generally involved in proliferation and 
utilization of nutrients. TORC1 stimulates general translation [52], as well as expression 
of ribosomal biogenesis genes [53] and ribosomal proteins [54]. It also promotes the 
transcription of genes involved in nitrogen utilization, such as permeases to facilitate 
import of nitrogen sources [55] (Figure 3.6 [56]). It is this response to nutrient levels, 
specifically to nitrogen availability that well positions TORC1 to regulate PHG. 
  
3.2.4.1. The TOR pathway in pseudohyphal growth 
 A large source of nitrogen available for cells comes from amino acids, specifically 
glutamine. When this preferred source of nitrogen is present, TOR inhibits the genes 
involved in utilization of suboptimal sources of nitrogen [57]. This inhibition is achieved 
by phosphorylation of the transcription factor Gln3p. Phosphorylated Gln3p is bound by 
the cytoplasmic protein Ure2p and sequestered from the nucleus. Nitrogen limitation 
results in the dephosphorylation of Gln3p by the TOR-dependent phosphatase Sit4p 
[57]. This allows Gln3p to localize to the nucleus and regulate transcription of nitrogen 
repressed genes. One such gene is Mep2p, an ammonium permease which is 
necessary for proper PHG [58]. TOR also stimulates the translation of Gcn4p under 
nitrogen stress [59]. In turn, Gcn4p binds in the promoter for FLO11 and activates 
transcription [60] (Figure 3.6). Yet more evidence of TOR signaling in pseudohyphal 
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growth is that chemical inhibition of the TOR complex inhibits PHG during nitrogen 
stress, but overexpression of the downstream target Tap42p restored PHG [61]. 
 
3.2.4.2. The TOR pathway in mRNP regulation 
 As mentioned in section 3.2.3.2. TORC1 has been found to be associated with 
stress granules, and this sequestration to granules is mediated by Pbp1p (Figure 3.5) 
[50]. Heat stress can also cause TORC1 to localize to stress granules [49]. Also, stress 
granule formation is induced upon  inhibition of translation, and TORC1 is known to 
positively regulate translation by phosphorylating and inhibiting proteins which bind to 
initiation factor eIF4E [62]. Therefore, inactivation of TORC1 leads to inhibition of 
translation initiation, which leads to the formation of stress granules.  
 
3.3. Summary 
 This chapter has introduced some of the many ways in which cells sense nutrient 
levels, transduce signals, and elicit an appropriate response. There are processes 
which have been omitted for the sake of concision but which certainly merit discussion. 
Decades of study have been undertaken to flesh out these pathways, and there is still 
work to be done. Noticeably missing from this discussion is the crosstalk among all of 
these pathways. All four pathways discussed above converge on the FLO11 promoter 
(Figure 3.8) [63]. Cells integrate signals regarding carbon and nitrogen availability, as 
well as physical stresses such as osmotic shock and heat stress, and each pathway 
weighs in on how to react. The net result is a response fine-tuned by eons of evolution. 
The complexity of these pathways makes controlling for unexpected consequences very 
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difficult, and any firm claims require copious verification via other experiments. Chapter 
IV highlights the signaling network of the Ksp1p kinase, and attempts to place it within 
the context of the signaling pathway milieu by using both a high-throughput proteomic 
approach and more targeted experimentation on putative targets of regulation.  
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Figure 3.1. Haploid and diploid Saccharomyces cerevisiae growth forms. Yeast 
can exists as a stable haploid or diploid. During haploid growth, mother cells grow, bud, 
and divide, yielding two separate and identical cells. If complementary mating types 
“fuse”, a diploid is formed. Under normal growing conditions, diploid yeast grow, bud, 
and divide in a manner analogous to haploid yeast. However, if nitrogen stress is 
encountered, yeast can switch to filamentous growth. During filamentous growth, cells 
elongate, bud in a unipolar fashion, and remain physically attached at the cell wall. 
Adapted from [3]. 
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Figure 3.2. Pseudohyphal growth causes changes in colony morphology. Wild 
type s1278b strain grown under normal conditions (left) or in nitrogen limiting conditions 
(right). 
 
  
78 
 
Figure 3.3. The cAMP/PKA/Ras pathway in filamentous growth and mRNP 
regulation. The membrane bound GPCR Gpr1 responds to glucose in the extracellular 
environment. The presence of glucose causes the release of the G-protein Gpa2 and 
activation of Ras. Both Gpa2 and Ras enhance the activity of the adenylate cyclase, 
Cyr1, which turns ATP in to cAMP. cAMP binds to the regulatory subunit of PKA, Bcy1, 
and the catalytic subunits, Tpk1/2/3 are activated. Tpk subunits differentially affect 
transcription of the major flocculence gene, FLO11. Tpk1 and Tpk2 are positive 
regulators of FLO11, while deletion of Tpk3 leads to hyperfilamentation. Tpk2 directs 
Flo8 to the FLO11 promoter between -1.4 Kb--1.0 Kb. The Phd1 binding site is not 
reported. Additionally, Tpk2 and Tpk3 localize to P-bodies during stationary phase. 
Tpk3 also localizes to P-bodies during glucose and osmotic stress. Deletion of Tpk3 
causes an increase in the percentage of cells containing P-bodies during glucose 
stress. Compiled from [4, 17, 18, 20-23]. 
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Figure 3.4. Five MAPK pathways and MAPK signaling in filamentous growth and 
mRNP regulation. MAPK signaling is involved in filamentous growth, mating, osmotic 
balance, cell wall integrity, and sporulation. These seemingly linear pathways also share 
many components, especially the filamentous growth, mating, and osmotic balance 
pathways (red dashed box). The MAPK Kss1 signals through the transcription factors 
Ste12 and Tec1 to affect transcription of FLO11. Also, the protein kinase Ste20, which 
functions upstream of many MAPK pathways, regulates the formation of stress granules 
by phosphorylating the P-body protein Dcp2. It also localizes, though inconsistently 
(dashed line), to stress granules during glucose stress. Compiled and adapted from [26-
31, 34-37]. 
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Figure 3.5. The SNF1 pathway in filamentous growth and mRNP regulation. The 
SNF1 complex functions to suppress glucose related genes when cells are grown on 
alternate carbon sources. Phosphorylation of the complex is performed by one of three 
upstream complexes, and dephosphorylation is performed by PP1. SNF1 also regulates 
FLO11 transcription by repressing the FLO11 transcriptional repressor Nrg1/2. Nrg1/2 
competes with Flo8 for binding to the FLO11 promoter. SNF1 dependent 
phosphorylation events may also help to sequester TORC1 to stress granules when 
nutrients are limited. Compiled and adapted from [24, 40-50, 64, 65]. 
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Figure 3.6. Invasion of a solid surface by haploid filamentous strains. Haploid 
filamentous strains were struck to rich media and allowed to grow for 3-5 days (Left; 
pre-wash). After incubation, plates were washed with deionized water and gently rubbed 
with a finger to remove surface cells. The degree of agar invasion is qualitatively 
measured by examining the density of the remaining cells below the surface (Right; 
post-wash). 
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Figure 3.7. The TOR pathway in filamentous growth and mRNP regulation. The 
TOR pathway responds to the extracellular nutrient availability, especially the availability 
of nitrogen. When conditions are favorable, TOR directs pathways which are involved in 
growth of the cells and inhibits stress responses. The TOR pathway also affects 
transcription of several genes involved in PHG, including FLO11. Compiled and adapted 
from [51-60, 66]. 
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Figure 3.8. Summary of FLO11 transcriptional regulation by four different signaling pathways. The transcription of 
FLO11 is influenced by all four pathways discussed (L to R: MAPK, PKA, SNF1, and TOR). Additionally, much of the 
regulation by these pathways is concentrated within the -2000 to -1000 range with respect to the transcriptional start site. 
The Phd1 binding site is not reported. 
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Chapter IV 
Proteomic analysis of the signaling network of the Saccharomyces cerevisiae 
kinase Ksp1p and discovery of a novel role in mRNP regulation. 
 
4.1. Introduction 
 The yeast kinase Ksp1p was first identified in a screen for high-copy suppressors 
of a mutation in the nucleotide exchange factor Srm1p [1]. However, almost two 
decades later Ksp1p remains mostly uncharacterized, especially with respect to its 
signaling network. Work in our lab has shown that Ksp1p, and specifically its kinase 
activity, is necessary for cells to transition from vegetative to pseudohyphal growth 
during nitrogen stress [2]. Briefly, under conditions of nutrient sufficiency, cells grow, 
bud, and divide rapidly and exhibit a mostly round morphology. When these same cells 
are starved for nitrogen, they become elongated and bud in a uni-polar fashion. 
Daughter cells do not completely separate from the mother cell and long chains of cells 
are formed [3]. This switch is often described as a foraging mechanism for the otherwise 
nonmotile yeast [4]. We also demonstrated that Ksp1p kinase activity is necessary for 
the wild type localization of three other pseudohyphal growth regulating kinases: Fus3p, 
Sks1p, and Bcy1p, the regulatory subunit of PKA [2]. 
 Several kinase signaling pathways are intimately involved in regulating 
pseudohyphal growth. The filamentous growth MAPK pathway and the MAP kinase 
Kss1p acts on the transcription factors Ste12p and Tec1p to stimulate transcription of 
the major flocculence gene FLO11 [5-7] (For review see [8]). The cAMP/PKA pathway
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 also acts on FLO11 via the transcription factor Flo8p [9], a pseudogene in most 
common laboratory strains [10]. An additional layer of regulation is provided by the TOR 
pathway [11].  
 The TOR pathway, and specifically the TOR1 complex (TORC1), acts to 
stimulate cell growth during nutrient sufficiency and activate stress response pathways 
during nutrient limitation [12]. The TOR pathway is especially necessary for sensing of 
nitrogen stress and amino acid availability [13]. Ksp1p has been linked to TORC1 in 
several ways. Most notably, Ksp1p has been shown to physically interact with TORC1 
via coimmunoprecipitation with complexes precipitated with the Kog1p subunit, and the 
same study showed that inhibition of TORC1 with rapamycin changes the 
phosphorylation state of Ksp1p [14]. Ksp1p has also been shown to be phosphorylated 
by PKA on Ser827 in a TOR dependent manner [15]. 
 Ksp1p has been shown to have an inhibitory effect on general autophagy, the 
trafficking of vesicles encompassing cytosolic proteins to the central yeast vacuole for 
processing and recycling under conditions of nitrogen stress. This inhibitory effect also 
appears to be mediated via TOR and PKA, as mutation of Ser827 of Ksp1p to alanine 
results in increased autophagy in low nitrogen conditions. A phosphomimetic 
Ser827Asp mutation conversely results in a decrease in autophagy [16].  
 Despite the mounting circumstantial evidence, the location of Ksp1p within the 
network of these pathways and processes remains a mystery, and as yet, no direct 
targets of Ksp1p phosphorylation have been definitively identified. Because of our 
interest in understanding the kinase signaling cascades involved in the regulation of 
pseudohyphal growth, we endeavored to examine global changes in the 
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phosphoproteome of a ksp1 kinase dead mutant as compared to a wild type strain 
under conditions which invoke a filamentous stress response. To do this, we employed 
a technique known as stable isotope labeling by amino acids in cell culture (SILAC) [17]. 
In this technique, wild type and mutant strains are differentially labeled with either “light” 
or “heavy” isotopes of lysine and arginine allowing for quantitative comparisons of their 
proteomes under a given growth condition . Here we present our findings, including 
differential phosphorylation states observed in 146 genes and 47 novel phosphorylation 
sites.  
To complement our proteomic study, we mined our data for Gene Ontology (GO) 
term enrichment [18] and found statistically significant enrichment for proteins involved 
in mRNA binding and stress granule assembly. Stress granules are ribonucleoprotein 
aggregates which form in the cytoplasm during many kinds of cellular stress [19, 20], 
though they are best characterized for their formation during glucose stress [21]. The 
general composition of these mRNPs includes mRNAs which have been stalled in 
translation, translation factors, and other mRNA binding proteins, but as they are 
studied further, the list becomes more diverse to include the likes of many kinases [22] 
and even TORC1 [23]. Though Ksp1p has been reported to localize to stress granules 
upon depletion of glucose, the GO term enrichment for stress granule assembly came 
as a surprise to us, as Ksp1p has never previously been reported to affect the dynamics 
of stress granule formation. Here, we show that Ksp1p does affect granule dynamics in 
response to high culture density, a known inducer of mRNP formation [24, 25]. Recent 
work in our lab has begun to draw connections between the improper formation of 
mRNP granules and defects in pseudohyphal growth (Shively, et al. manuscript in 
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progress). To that end, we followed up on three specific genes known to localize to, or 
regulate the formation of, stress granules which were differentially phosphorylated in a 
ksp1 kinase dead background as revealed by SILAC. We found that mutation of specific 
residues in Pbp1p, Tif4631p, and Ste20p had differential effects on pseudohyphal 
growth phenotypes and localization of these proteins to cytoplasmic foci after growth to 
high optical density. 
 With this study, we have generated a putative target list for Ksp1p kinase activity. 
We have also demonstrated a role for Ksp1p in regulating the formation of stress 
granules under some conditions. More importantly, we have succeeded in implicating 
specific residues of three proteins from our SILAC data as being important for 
pseudohyphal growth, localization to mRNP granules, or both. These results, as well as 
targeted follow-up studies, will eventually place Ksp1p in the complex network of the 
yeast signaling pathways. 
 
4.2. Materials and methods 
4.2.1. Strains, media, and growth conditions 
 The strains used in this study are listed in Table 4.1. Diploid filamentous strains 
were constructed in the Σ1278b background by mating the Y825 and HLY337 haploid 
strains [26]. Fluorescence microscopy was performed using the S288C derivatives 
BY4742 and BY4741 [27].  
 Standard yeast techniques and growth media were used to culture cells [28]. 
Under normal conditions, cells were grown in complete media, either YPD (2% peptone, 
1% yeast extract, and 2% glucose, with or without 2% agar) or Synthetic Complete (SC) 
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(0.67% yeast nitrogen base, 2% glucose, and 0.2% of the appropriate amino acid 
dropout mix, with or without 2% agar). Low nitrogen conditions were achieved by growth 
in or on Synthetic Low Ammonia Dextrose (SLAD) (0.17% yeast nitrogen base without 
amino acids and without ammonium sulfate, 2% glucose, 50µM ammonium sulfate, and 
the appropriate amino acids to complement auxotrophies).  
 Plasmids used in this study are listed in Table 4.2. The plasmid pDS7 (U1A-
mCherry) was made by amplification of the mCherry protein from plasmid pBS35 [29] 
using DSK116 and DSK117, and amplification of the pRP1194 backbone [30] using 
DSK114 and DSK115. PCR products obtained were used for Gibson Assembly using 
Gibson Assembly Master Mix (NEB).  
 
4.2.2. Construction of chromosomal mutants and fusions 
 Chromosomal deletions of genes were made using a one-step PCR-based 
protocol for gene disruption by amplifying the kanMX6 gene from plasmid pFA6a-
kanMX6 [31]. Transformants were selected by plating on YPD + G418 plates and 
verified by PCR. Deletion of KSP1 was done using oCK0327 and oCK0328. Deletion of 
TIF4631 was done using oCK0265 and oCK0266. Deletion of PBP1 was done using 
oCK0259 and oCK0260. Deletion of STE20 was done using oCK0263 and oCK0264. 
Similarly, C-terminal GFP fusions were made by transformation of strains with PCR 
product obtained after amplification of the GFP::HisMX6 cassette from pFA6a-
GFP::HisMX6 [31]. PBP1 was tagged using DSK009 and DSK010. STE20 was tagged 
using DSK118 and DSK119. 
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Chromosomally integrated point mutants were made using a URA3 knock-in-
knock-out method as previously described [32]. Briefly, the URA3 gene was amplified 
from vector pRS406 with primers containing homology to 45 base pairs of sequence on 
either side of the mutational target site. Strains were transformed with PCR product and 
selected for on media lacking uracil. Strains with successful URA3 insertions were 
transformed with annealed 120-mer oligonucleotides containing the desired mutant 
sequence and homology to flanking regions. Successful loss of URA3 was monitored by 
screening on 5-FOA plates. Mutations in KSP1 were made using DSK096, DSK097, 
DSK100, and DSK101. Mutations in TIF4631 were made using oCK0448, oCK0449, 
oCK0450, oCK0451, oCK0452, oCK0453, DSK024, and DSK025. Mutations in PBP1 
were made using DSK028, DSK029, DSK034, DSK035, DSK0121, and DSK122. 
Mutations in STE20 were made using oCK0656, oCK0657, oCK0658, and oCK0659. 
 
4.2.3. Peptide sample preparation and phosphopeptide enrichment 
S. cerevisiae Y825 control and ksp1K47D mutant cells were isotopically labeled 
with heavy (Lys-8/Arg-10) amino acids during cell culture (SILAC). Cell cultures were 
lysed by bead beating in lysis buffer; the lysis buffer was composed of 50 mM tris buffer 
(pH 8.2), 8 M urea, and protease inhibitors (Roche) and phosphatase inhibitors (50 mM 
NaF, 50 mM beta-glycerophosphate, 1 mM sodium vanadate, 10 mM sodium 
pyrophosphate, 1 mM phenylmethylsulfonyl fluoride). Frozen cells were suspended in 
400 μl lysis buffer and were lysed by applying three cycles of bead beating (for one 
minute each) with a 2-minute rest on ice between cycles. Supernatants containing 
protein extract were recovered by centrifugation at 14,000 g for 10 minutes, and protein 
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concentrations were measured by Bradford assay. Equal amounts of protein from three 
SILAC-labeled cells were combined, treated for disulfide reduction and alkylation, and 
digested with TMPK-treated trypsin (Worthington Biochemical Corp., Lakewood, NJ) at 
a trypsin:protein ratio of 1:10 at 37 °C overnight.  
Peptide mixtures were desalted with C18 (Waters) and separated into 12 strong 
cation exchange (SCX) fractions on a PolySulfoethyl A column (PolyLC, 150 x 4 mm) 
over a 48 minute salt gradient with two mobile phases: 100% solvent A (5 mM KH2PO4, 
30% acetonitrile, pH 2.7) for 5 minutes, a linear gradient of 0-40% solvent B (250 mM 
KH2PO4, 30% acetonitrile, pH 2.7) in the following 35 min, a stiff increase of 40-100% B 
in 3 min, and flushing with 100% B for 5 min. Collected SCX fractions were desalted 
with C18 (Waters) and subjected to selective phosphopeptide enrichment using ZrO2 
(Glygen, 50 μm i.d. resin) under acidic conditions in the presence of 2,5-dihydroxy 
benzoic acid (52, 53). Phosphopeptides selectively bound on ZrO2 were eluted with 4% 
NH4OH. The ZrO2 eluate of enriched phosphopeptides and the flow-through of each 
SCX fraction were analyzed by nanoLC-tandem mass spectrometry (MSMS). 
 
4.2.4. Mass spectrometric analysis and SILAC quantification 
NanoLC-MSMS experiments were performed on a hybrid type mass 
spectrometer (Thermo, LTQ-Orbitrap XL) coupled to a nanoLC system (Eksigent, 2D 
nanoLC). Samples were separated on a custom capillary column (150 mm x 75 μm, 3 
μm Sepax HP-C18) using a 120 min linear aqueous gradient (9-90% acetonitrile, 0.01% 
formic acid) delivered at 250 nL/min. The eluent was introduced on-line to the LTQ-
Orbitrap via an electrospray device (Advion, TriVersa NanoMate) in positive ion mode.  
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The LTQ-Orbitrap was operated in a data-dependent mode alternating a full MS 
scan (300-1700 m/z at 60,000 resolution power at 400 m/z) in the Orbitrap analyzer and 
collision-induced dissociation scans (CID-MSMS) for the 7 most abundant ions with 
signal intensity above 500 from the previous MS scan in LTQ. Recurring precursor ions 
were dynamically excluded for 30 sec by applying charge-state monitoring, ions with 1 
or unassigned charge states were rejected to increase the fraction of ions producing 
useful fragmentation. Lock mass ([(Si(CH3)2O)6]1+, m/z = 445.120029) was used for 
internal calibration. Each sample was analyzed by two LC-MS experiments. Raw LC-
MS data file sets were processed, database searched, and quantified using MaxQuant 
(ver 1.0.13.8) (54) and the Mascot search engine together. Mascot database searches 
were performed against a composite database of forward and reverse sequences of 
verified yeast open reading frames from the Saccharomyces Genome Database. 
Variable modifications were allowed for oxidation (M) and phosphorylations (STY), as 
well as a fixed modification of carbamidomethylation (C). Peptide, protein, and 
phosphorylation site identifications were filtered at a false discover rate of 5%. The 
MaxQuant normalized H/L (heavy/light) ratios with significance scores less than 0.05 
were considered statistically significant.  
 
4.2.5. Surface spread filamentation and invasion assays 
Cultures of diploid wild type or mutant strains were grown overnight in YPD, back 
diluted 1:20 in fresh YPD, and grown for 4-6 h. Cells were washed 3 times with sterile 
deionized water and normalized to a final OD600 of 1.0 before being diluted and plated 
to SLAD plus uracil at a density of approximately 50 cells/plate. Plates were incubated 
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at 30oC for until filamentation was observed in wild type strains (about 7-8 days) before 
being visualized. After images were taken of representative colonies, invasion into the 
agar was assayed by running plates under deionized water and gently removing surface 
cells with a finger. Plates were dried and reimaged. 
 
4.2.6. β-galactosidase assays of FLO11 transcription activity 
 Diploid strains harboring plasmid pGL669-Z FLO11 6/7 [33] were grown 
overnight in SC minus uracil. Cells were washed 3 times with 2% glucose, diluted 1:5 in 
SLAD media, and grown at 30oC for 4-6 h. B-galactosidase assays were performed in 
triplicate using Thermo Scientific Yeast β-Galactosidase Assay Kit according to the 
manufacturer’s protocols. 
 
4.2.7. Induction and visualization of mRNP granules 
 Strains harboring pPS2037 and pDS7 were grown overnight in SC minus uracil 
and leucine. Cultures were back diluted to OD600 of 0.1, and incubated at 30oC. 
Formation of granules and colocalization was monitored at 24 h and 48 h using a Nikon 
Eclipse 80i microscope, X-Cite 120 lamp, and MetaMorph imaging software (Version 
7.1.2.0). 
 
4.3. Results 
4.3.1. Analysis of the Ksp1p signaling network 
 SILAC experiments, performed and quantified in the lab of Phil Andrews, 
comparing phosphorylation states between a wild type strain and a kinase dead version 
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of ksp1 (Figure 4.1) yielded 180 peptides with altered phosphorylation (Figure 4.2A and 
Table 4.7) across 146 unique genes. Of those, 43 were observed to be 
hyperphosphorylated (Table 4.3) and 147 hypophosphorylated (Table 4.4). In addition, 
6 genes were observed to contain both hyper and hypophosphorylated peptides (Figure 
4.2B). Though a decrease in phosphorylation must be an indirect effect, these changes 
can still give insight into the regulatory network of Ksp1p and are useful in looking at 
possible connections among various signaling pathways and Ksp1p. Within the 180 
peptides identified, we also report discovery of 47 novel phosphorylation sites (Table 
4.6). 
 To begin analyzing the proteomic data a little deeper, we used available 
computational tools to look at Gene Ontology (GO) Terms which are enriched in our 
data set compared to background. These programs compare the proportion of genes 
within a specified dataset which are annotated for a particular cellular process or 
function to the overall proportion of genes which are ascribed that same process or 
function in the entire genome. The results of this analysis are highlighted in Figure 4.3. 
It was not surprising to us that our data set was enriched for protein kinases and kinase 
activity, but it is worth noting that these kinases represent diverse signaling pathways. 
For example, we observe differential phosphorylation of the MAPK-pathway kinase 
Ste20p, the PKA-regulated kinase Yak1p, and Hxk1, a kinase downstream of the 
glucose sensing Snf1 pathway. Also statistically enriched in our data set were genes 
involved in trehalose metabolism (Figure 4.3B). Trehalose is a disaccharide and is 
hydrolyzed into two glucose molecules by Nth1p or Nth2p. Together, these results seem 
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to position Ksp1p to facilitate crosstalk among several pathways, perhaps coordinating 
a less linear, and more nuanced, response to extracellular nutrient levels. 
 In addition to kinase activity and metabolic pathways, we were struck by the large 
number of genes in the data set which are known to bind to mRNA and regulate the 
formation of stress granules (Figure 4.3B). Ksp1p had been previously shown to localize 
to cytoplasmic foci upon glucose stress, but it was reported that Ksp1p did not affect the 
formation of stress granules. In light of this enrichment, and previous results from our 
lab demonstrating the link between mRNP formation and pseudohyphal growth, we to 
examined the phenotypic consequences of mutations of several of these genes. In 
particular, because of the reported localization of Ksp1p, we were interested in the 
genes which have been most closely linked to stress granules. Pbp1p and Tif4631 have 
both been shown to localize to stress granules, and Ste20p has been implicated in 
regulating the formation of stress granules via phosphorylation of Dcp2p and has been 
reported to occasionally localize to granules. 
 
4.3.2. Mutation of SILAC-identified residues affects pseudohyphal growth and 
invasion 
 Diploid integrated point mutants in PBP1, TIF4631, STE20, and KSP1, in the 
filamentous Σ1278b background, were assayed for their ability to undergo 
pseudohyphal growth and invade the agar surface on low nitrogen media (Figure 4.4 
and Figure 4.5). As we have previously reported, Ksp1p is necessary for robust 
pseudohyphal growth, and mutation of the kinase activity is sufficient to cause this 
defect. In this way, ksp1 mutants serve as a negative control.   
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Complete deletions of KSP1, TIF4631, PBP1, and STE20 cause severe 
pseudohyphal growth defects, with little to no filamentation observed in PBP1 and 
STE20 (Figure 4.4). Deletion of PBP1 or STE20 also ablates invasion (Figure 4.5). The 
kinase dead mutant ksp1K47D is also defective for pseudohyphal growth.  
More interestingly, non-phosphorylatable alleles of tif4631 suggest that Ser176 is 
necessary for robust pseudohyphal growth. Though filaments can be observed in this 
strain, they are abnormal in appearance. Ser180 did not have an effect on filamentation, 
and the double mutant exhibited an intermediate phenotype. Mutations of TIF4631 did 
not greatly alter the invasive phenotype of these cells (data not shown).  
Ser456 of Pbp1p was hyperphosphorylated in our SILAC experiment. Here, we 
changed Ser456 to alanine, essentially making it constitutively hypophosphorylated. In 
the pseudohyphal growth assay, we observed very large colonies with little to no 
surface-spread filamentation, but this mutation confers a hyperinvasive phenotype. For 
its part, the ste20T203A mutant did not have a consistently appreciable effect on surface 
spread filamentation or invasive growth. 
 
4.3.3. Mutants are defective for PKA control of FLO11 transcription 
 As a complement to the more qualitative pseudohyphal and invasive growth 
assays, we used a LacZ reporter construct to measure transcription of the FLO11 gene, 
a gene essential for formation of filaments. The FLO11 promoter is unusually large and 
is controlled by both the filamentous growth MAPK pathway and the PKA pathway. 
Reporter constructs have been made which separate the MAPK-responsive and PKA-
responsive locations of the FLO11 promoter and active transcription can be measured 
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by standard β-galactosidase assays. No differences were observed using the MAPK-
responsive construct (data not shown), but statistically significant differences were seen 
among the mutants with the PKA-responsive reporter (Figure 4.6). 
 Again, all null mutants were decreased for transcription of FLO11, even ste20Δ, 
which is known to function upstream of the MAPK pathway. It should be noted, 
however, that Thr203 of Ste20p resides in a consensus PKA kinase motif, so Ste20p 
may also facilitate crosstalk between pathways, but there was no statistically significant 
change in the FLO11 transcription in a ste20T203A background. 
 The FLO11 transcriptional activity in the pbp1Δ and pbp1S436A mutants 
complemented the observed phenotypes in plate assays. The null mutant exhibited a 
70% decrease in PKA-dependent FLO11 transcription, while the non-phosphorylatable 
mutant showed a 30% increase.  
 In the various TIF4631 backgrounds, transcription of this reporter is varied, as 
are the pseudohyphal growth phenotypes. Here again the tif4631S180A mutant did not 
cause a significant change in transcription. Oddly, even though the tif4631S176A and 
tif4631Δ mutants both led to decreased activity, the point mutant exhibited a greater 
decrease (about 30% of wild type activity in the point mutant versus 80% of wild type 
activity in the null mutant). This result is slightly perplexing, and it will require a greater 
understanding of the role of Ser176 in vivo. The tif4631S176,180A mutant was again 
intermediately defective compared to the single mutants. Though it still exhibits about 
90% of the activity of wild type, the difference was consistent and statistically significant. 
 
4.3.4. Ksp1p affects mRNP granules formed during high-OD stress 
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 Ksp1p has not previously been implicated in regulating the formation of mRNP 
granules. It is important to note that the composition of mRNP granules and dynamics of 
their assembly can vary greatly depending on induction conditions. Most commonly, 
mRNP formation is induced by acutely starving cells in the logarithmic-growth phase for 
glucose. Other induction conditions commonly used include: heat stress, inhibition of 
translation, or high culture density. In our assay, the most consistent results were 
obtained using this latter method, and mRNP formation was observed after growth to 
high OD. To monitor the formation of mRNPs, we replaced the GFP moiety of the 
plasmid pRP1194 with mCherry via Gibson Assembly (see methods). This also allowed 
us to examine colocalization with GFP-tagged strains from the available GFP collection. 
 Wild type and ksp1 mutant strains were transformed with the reporter plasmids, 
allowing us to track the formation of mCherry-marked PGK-mRNA containing foci 
through U1A binding. High optical density stress was induced by back dilution of 
overnight cultures into Synthetic Complete media to a starting OD600 of 0.1 and growth 
at 30oC for 24-48 hours. After 48 hours, both the null and kinase dead mutants of ksp1 
consistently exhibited nearly a 3-fold increase in the percentage of cells containing at 
least 1 focus with the modified PGK1 transcript. This result suggests that Ksp1p may 
play a role in inhibiting, or at least slowing, the formation of stress granules in aging 
cultures 
 
4.3.5. Pbp1p and Ste20p point mutants have aberrant mRNP phenotypes 
 As mentioned, Pbp1p and Tif4631p have been classified as stress granule 
components. Ste20p has been shown to regulate stress granule formation by 
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phosphorylating the P-body associating protein Dcp2p, a necessary step in the 
formation of stress granules. We wished to examine the localization pattern of wild type 
Tif4631p-GFP, Pbp1p-GFP, Ste20p-GFP, as well as the localization of the point 
mutants used in the pseudohyphal growth assays. Here we utilized the PGK/mCherry 
system in combination with GFP-tagged wild type and mutant versions of Tif4631p, 
Pbp1p, and Ste20p to allow for quantification of both GFP focus formation and potential 
changes in the colocalization patterns. No consistent phenotypes were observed in the 
various TIF4631 backgrounds (data not shown). 
 For Pbp1p, we compared the relative granule formation between wild type and 
the pbp1S436A mutant as well as between wild type and a phosphomimetic pbp1S436D 
mutant (Figure 4.8). The most striking phenotypic differences were observed at 24 h, 
when both mutants consistently had a higher percentage of cells containing foci relative 
to wild type (Figure 4.8 and quantified in Figure 4.9). No marked differences from wild 
type were observed after 48 h (see discussion). Interestingly, the colocalization 
phenotypes are different between the two strains at 24 h (Figure 4.8). Though both 
mutants had more foci, the Ser456Ala mutant was slightly, though statistically 
significantly, decreased for colocalization with the mCherry-marked PGK1-U1A-binding 
site foci. The Ser456Asp showed almost 2-fold more colocalization than wild type 
Pbp1p-GFP. Based on these results Ser456 is important for wild type formation and 
localization of Pbp1p granules. 
 The ste20T203A mutant also had differential localization patterns compared to wild 
type (Figure 4.10 and quantified in Figure 4.11). At 48 h the ste20T203A mutant had a 
2.5-fold increase in foci formation compared to wild type. The increase in foci formation 
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at 48 h was concomitant with an increase in colocalization with PGK containing foci. It is 
possible that Thr203 is necessary for movement of Ste20p out of these granules.  
 
4.4. Discussion 
 Here we present a proteomic survey of the kinase signaling network of Ksp1p 
and potential downstream targets of Ksp1p regulation. Of particular note is the breadth 
of the potential Ksp1p targets which include members of three major filamentous growth 
signaling pathways: the PKA pathway, the MAPK pathway, and the Snf1 pathway 
(Figure 4.2). There were no observed changes in the phosphorylation of any TORC1 
proteins, but Tsc11p (Avo3p), a member of the TORC2 complex was 
hypophosphorylated in the mutant ksp1 background (Table 4.5). 
 Utilizing the phosphoproteomic data presented here, and previous data showing 
Ksp1p to immunoprecipitate with TORC1 [14], regulate autophagy in a TOR-dependent 
manner [16], as well as data showing Ksp1p phosphorylation by PKA to be dependent 
upon TOR [15], it is possible to speculate as to the location of Ksp1p within these many 
signaling networks, with respect to pseudohyphal growth (Figure 4.12). Likely, Ksp1p 
resides downstream of both TORC1 and PKA, and though Ksp1p is necessary for the 
proper response to nitrogen limitation, it may help cells to respond to glucose stress. 
Evidence of this comes from the fact that putative targets of Ksp1p include genes 
involved in trehalose metabolism (Figure 4.3), as well as the aberrant formation of 
stress granules in ksp1 mutant strains (Figure 4.7, Figure 4.13), as stress granule 
formation is a response to glucose depletion. 
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 Further bolstering the position of Ksp1p at least partially within the PKA pathway 
are the results of the FLO11 transcriptional reporter assay (Figure 4.6). Both the null 
and kinase dead alleles of ksp1 exhibited decreased PKA-dependent transcription of 
FLO11. Moreover, point mutations of residues implicated by the SILAC data also 
exhibited a decrease in transcription of FLO11. 
 Proteomic data has begun to help us place Ksp1p within its signaling network, 
but it has also yielded a potentially novel role for Ksp1p in the regulation of stress 
granule formation (Figure 4.12, Figure 4.13). Because of the enrichment of stress 
granule associating and regulatory proteins present in our data set, we looked at the 
effects, not only on general granule formation in the ksp1Δ and ksp1K47D backgrounds, 
but also at the effects of SILAC-implicated residues on the localization of Tif4631p, 
Ste20p, and Pbp1p after growth to high OD (Figures 4.7-4.11).  
Mutation of ksp1 resulted in a higher percentage of cells containing PGK foci 
after 48 hours (Figure 4.7, Figure 4.13). Again, this suggests that Ksp1p plays a role in 
inhibiting granule formation, and this inhibition is dependent upon Ksp1p kinase activity. 
If Ksp1p is acting to stimulate the hydrolysis of trehalose into glucose by Nth1p and 
Nth2p, this may explain why granules form more quickly in these strains. A decrease in 
trehalose hydrolysis would exacerbate any glucose stress present. While Nth2p is 
hypophosphorylated in our data set, Nth1p exhibits a “mixed” state with one peptide 
being identified as being hypophosphorylated and one peptide being 
hyperphosphorylated.  
Mutations of two of the three individual stress granule proteins yielded changes 
in their localizations (Figure 4.8-4.11, 4.13). The tif4631 alleles tested showed no 
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consistent phenotypes and were not examined further in this study. Mutation of Thr203 
of Ste20p led to an increase in the number of ste20T203Ap-GFP foci present at 48 h. 
These foci were also 1.5 times more likely to colocalize with foci containing the modified 
PGK1 transcript. It is possible that the phosphorylation state of Thr203 acts to mediate 
whether or not Ste20p enters granules, or this residue may facilitate the exit of Ste20p 
from the U1A-marked granules. 
The results seen in the PBP1 alleles are intriguing. First, it must be addressed 
that the most significant difference in granule formation compared to wild type was seen 
at 24 h (Figure 4.8 and Figure 4.9). At the 48 h time point, neither allele exhibited a 
localization pattern different from that of wild type (data not shown). One possible 
explanation for this could be that at 24 h, cells are either still in late logarithmic phase, at 
the cusp of undergoing diauxic shift., or have just undergone the shift. Diauxic shift 
occurs when nearly all of the available glucose is consumed by fermentation, and the 
yeast must shift to respiration and growth on the alcohols produced by fermentation 
[34]. Both PKA and TOR are negative regulators of this diauxic shift (For review see 
[35]), and Pbp1p has been demonstrated to help recruit TORC1 to stress granules [23]), 
possibly as a means of sequestering it. It will be interesting to determine if the increased 
foci formation affects timing of the diauxic shift in the pbp1 mutant relative to wild type. 
Nevertheless, both the nonphosphorylatable pbp1S456Dp-GFP and the phosphomimetic 
pbp1S456Dp-GFP constructs formed more foci than wild type at 24 h. This suggests that 
this residue is important for regulating wild type levels of Pbp1p-GFP granule formation, 
but the phosphorylation state of this residue is not sufficient to govern its localization to 
granules. 
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When colocalization of these mutant alleles with U1A-marked granules is 
examined, we find that the pbp1S456A mutant is slightly decreased for the proportion of 
GFP foci which colocalize with mCherry-marked foci. Conversely, the pbp1S436D mutant 
shows nearly a 2-fold increase in colocalization. This seems to implicate this residue in 
trafficking Pbp1p to the “correct” cytoplasmic granule. The immutable nature of these 
mutants may decrease the ability of Pbp1p to move between different types of mRNP 
granules. Lastly, it is possible that these point mutants could be having an effect on 
formation of foci with the modified PGK1 transcript, but we observed no significant 
differences between U1A-marked foci formation in wild type and our point mutants (data 
not shown). 
Synthesis of the results yields a speculative model for Ksp1p function during 
stress (Figure 4.12 and Figure 4.13). Ksp1p kinase activity is a positive regulator of 
pseudohyphal growth, but a negative regulator of mRNP formation. As these two 
processes are both activated in response to nutrient limitation, it seems Ksp1p is 
playing somewhat divergent roles. Traditionally, filamentous growth is a response to low 
nitrogen, while mRNP formation is a response to glucose stress. As the signaling 
pathways discussed respond to diverse stimuli, Ksp1p may play differing roles during 
nitrogen and glucose stresses. During nitrogen stress, Ksp1p signals, at least indirectly, 
through several known mRNP associated proteins to affect PKA-dependent 
transcription of FLO11. The catalytic subunits of PKA, either Tpk1 or Tpk2, then cause 
an increase in the transcription of FLO11, and consequently, filamentous growth (Figure 
4.6 and Figure 4.12). Formation of mRNPs is not traditionally studied during nitrogen 
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stress, so it remains unknown if Pbp1p, Ste20p, or Tif4631p form foci under these 
conditions, but it is unlikely. 
 I do not observe an effect for Ksp1p on mRNA granule formation during acute 
glucose stress. Ksp1p foci form consistently when cells are grown to high OD by 
culturing for 24-48 hours. This long growth naturally leads to the consumption of 
glucose via fermentation, stressing the cells, though more gradually. Under these 
conditions, mRNA granules form in the presence of Ksp1p, but only in approximately 
5% of cells. Loss of Ksp1p, or its kinase activity, results in mRNA foci occurring in 
approximately 15% of cells (Figure 4.7). Mutation of phosphorylation sites on Ste20p 
and Pbp1p whose phosphorylation states have been shown by SILAC to be regulated 
by Ksp1p also leads to an increase in foci formation by these proteins, further 
demonstrating that Ksp1p acts to retard formation of granules.  
Ksp1p kinase activity may inhibit RNP granule formation through several means. 
Ksp1p may directly phosphorylate a protein component of RNP granules, thereby 
decreasing affinity for other granule proteins. Ksp1p may phosphorylate a component of 
the TORC1 complex, affecting nutrient-responsive signaling, and indirectly, RNP 
granule formation. Ksp1p may also regulate mRNP granule number through the PKA 
pathway, which is known to negatively regulate P-body formation in response to glucose 
stress. Our data, as well as data indicating TORC1-dependent PKA phosphorylation of 
Ksp1p, most directly relates to the latter two possibilities, although the mechanism of 
this regulatory control remains to be determined. Collectively, the retardation of granule 
formation by Ksp1p may be a mechanism by which the cells prevent the unnecessary 
formation of granules in the absence of dire stress conditions. However, once a 
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particular threshold has been reached, Ksp1p may signal through Pbp1p to sequester 
TORC1 and PKA, and potentially itself via a physical interaction with TORC1, to 
granules, completely releasing the brake on granule formation (Figures 4.7-4.11 and 
Figure 4.13). At present, further experimentation is needed to test this model.
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Figure 4.1. Experimental design for discovery of differentially phosphorylated 
peptides. Filamentous strains harboring a ksp1Δ allele were transformed with either 
wild type or a kinase dead mutant of KSP1 under control of its native promoter. Strains 
were grown in minimal media with “light” or “heavy” amino acids, plus 1% butanol to 
induce filamentation in liquid culture. Protein preparations were mixed, digested, and 
enriched for phosphopeptides before being subjected to LC-MS/MS. Adapted from [26]. 
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Figure 4.2. Overview of genes with altered phosphorylation in a ksp1K47D strain. 
(A) List of all non-redundant genes to which a peptide was mapped and observed to be 
hyperphosphorylated (green) or hypophosphorylated (red). Relevant numbers are given 
in green and red boxes to the right. (B) Genes to which independent peptides showed 
both types of aberrant phosphorylation. 
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Figure 4.3. Analysis of Gene Ontology (GO) Terms. (A) Highlights of some GO 
Terms for Cellular Function, their p-values for enrichment, and their member genes. (B) 
Highlights of some GO Terms for Cellular Process, their p-values for enrichment, and 
their member genes. 
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Figure 4.4. Diploid pseudohyphal growth phenotypes. Cells in the logarithmic 
growth phase were washed with sterile water and approximately 50 cells/plate were 
spread to SLAD (low nitrogen) plates. Representative images of multiple replicates of 
surface spread filamentation assays with diploid cells are shown. Relative phenotypes 
are represented by “+” (wild type) and “-“ (decreased) pseudohyphal growth. 
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Figure 4.5. Diploid agar invasion phenotypes. Cells in the logarithmic growth phase 
were washed with sterile water and approximately 50 cells/plate were spread to SLAD 
(low nitrogen) plates and allowed to invade the agar. Representative images of multiple 
replicates of agar invasion assays with diploid cells are shown. Relative phenotypes are 
represented by “+” (wild type), “-“ (decreased), “- -“ (severely decreased) and “++” 
(increased) invasive growth. 
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Figure 4.6. Quantification of PKA-dependent FLO11 transcription. Diploid cells, of 
the specified genotype, were transformed with pLG669-Z FLO11 6/7 and monitored for 
PKA-dependent FLO11 transcription via β-galactosidase assays in triplicate. Miller units 
of mutants were normalized to wild type and fold-change is reported on the Y-axis. 
Statistical significance is indicated by asterisks (p < 0.01 “***”, p < 0.05 “**”, p < 0.10 
“*”). 
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Figure 4.7. Dynamics of PGK mRNA-containing mRNP granules in various KSP1 
backgrounds. (A) The indicated strain was transformed with pPS2037 (PGK-U1A 
mRNA), and pDS7 (U1A-mCherry) and monitored for focus formation after 48 hour of 
growth in SC minus uracil, minus leucine. (B) Quantification and statistical analysis of 
three paired replicates. The percentage of mutant cells exhibiting foci was normalized to 
wild type and fold-change is reported on the Y-axis. Statistical significance is indicated 
by asterisks (p < 0.01 “***”, p < 0.05 “**”, p < 0.10 “*”). (Data is from 3 replicates; Ncells ≥ 
250; ?̅?𝑥 Rwildtype = 4.7%). 
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Figure 4.8. Dynamics of Pbp1p-GFP and MS implicated mutant pbp1p-GFP foci. 
Wild type, non-phosphorylatable, and phosphomimetic mutants of Pbp1p were fused to 
GFP and transformed with pPS2037 and pDS7. Formation of GFP-foci and 
colocalization with mCherry-marked PGK-foci was monitored after 24 hours of growth in 
SC minus uracil, minus leucine. 
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Figure 4.9. Quantification of Pbp1p-GFP and MS implicated mutant pbp1p-GFP 
foci dynamics. Wild type and mutant fusion proteins were imaged after 24 hours of 
growth in SC minus uracil, minus leucine and the percentage of cells containing GFP 
foci, as well as the percentage of those foci which colocalized with PGK mRNA-
containing foci was determined. The percentage of mutant cells exhibiting foci or 
colocalizing with PGK granules was normalize to wild type and fold-change is reported 
on the Y-axis. Statistical significance is indicated by asterisks (p < 0.01 “***”, p < 0.05 
“**”, p < 0.10 “*”).(Data is from 4 replicates; Ncells ≥ 150; Foci ?̅?𝑥 Rwildtype = 9.4%; 
Colocalization ?̅?𝑥 Rwildtype = 42.6%). 
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Figure 4.10. Dynamics of Ste20p-GFP and MS implicated mutant ste20p-GFP foci. 
Wild type and a non-phosphorylatable mutant of Ste20p was fused to GFP and 
transformed with pPS2037 and pDS7. Formation of GFP-foci and colocalization with 
mCherry-marked PGK-foci was monitored after 48 hours of growth in SC minus uracil, 
minus leucine. 
 
 
 
  
  
120 
 
Figure 4.11. Quantification of Ste20p-GFP and MS implicated mutant ste20p-GFP 
foci dynamics. Wild type and mutant fusion proteins were imaged after 48 hours of 
growth in SC minus uracil, minus leucine, and the percentage of cells containing GFP 
foci, as well as the percentage of those foci which colocalized with PGK mRNA-
containing foci was determined. The percentage of mutant cells exhibiting foci or 
colocalizing with PGK granules was normalize to wild type and fold-change is reported 
on the Y-axis. Statistical significance is indicated by asterisks (p < 0.01 “***”, p < 0.05 
“**”, p < 0.10 “*”).(Data is from 5 replicates; Ncells ≥ 150; Foci ?̅?𝑥 Rwildtype = 3.9%; 
Colocalization ?̅?𝑥 Rwildtype = 38.6%). 
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Figure 4.12. A partial Ksp1p signaling network. Deletions of all SILAC implicated 
genes show an affect on FLO11 transcription via the PKA pathway, Additionally, some 
SILAC implicated residues are functionally important for PKA-dependent FLO11 
transcription. PKA also phosphorylates Ksp1p in a TOR-dependent manner, and Ksp1p 
has an inhibitory effect on mRNP formation during high-OD stress. 
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Figure 4.13. Ksp1p in mRNP formation. During high-OD stress, Ksp1p functions as a 
“brake” on mRNP formation. Mutation of SILAC-implicated residues on Ste20p and 
Pbp1p results in an increase in those proteins localizing to foci. Additionally, these 
residues are important for wild type localization of Ste20p and Pbp1p to mRNA foci. 
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Table 4.1. Yeast strains used in this study 
 
Strain Genotype Source 
HLY337  ura3-52 trp1-1 MATα   
Y825 ura3-52 leu2Δ0 MATa   
BY4742 his3Δ1 leu2Δ0 lys2D0 ura3Δ0 MATα [36] 
yCK021 
(825x337) ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα [26] 
yCK109 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα ksp1Δ::kanMX/ksp1Δ::kanMX This study 
yCK186 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα ksp1K47D/ksp1K47D This study 
yCK061 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα tif4631Δ::kanMX/tif4631Δ::kanMX This study 
yCK190 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα tif4631S176A/tif4631S176A This study 
yCK235 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα tif4631S180A/tif4631S180A This study 
DSY035 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα tif4631S176,180A/tif4631S176,180A This study 
yCK059 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα pbp1Δ::kanMX/pbp1Δ::kanMX This study 
DSY178 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα pbp1S436A/pbp1S436A This study 
DSY245 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα pbp1S436D/pbp1S436D This study 
yCK083 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα ste20Δ::kanMX/ste20Δ::kanMX This study 
yCK336 ura3-52/ura3-52 leu2Δ0/LEU2 TRP1/trp1-1 MATa/MATα ste20T203A/ste20T203A This study 
DSY052 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 PBP1-GFP-HIS3MX6 MATa [27] 
DSY179 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pbp1
S436A-GFP::HisMX 
MATa This study 
DSY241 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pbp1
S436D-GFP::HisMX 
MATa This study 
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DSY226 his3Δ1 leu2Δ0 lys2D0 ura3Δ0 Ste20-GFP::His3MX6 MATα [27] 
DSY240 his3Δ1 leu2Δ0 lys2D0 ura3Δ0 ste20
T203A-GFP::His3MX6 
MATα This study 
DSY160 his3Δ1 leu2Δ0 lys2D0 ura3Δ0 ksp1Δ::KanMX MATα This study 
DSY161 his3Δ1 leu2Δ0 lys2D0 ura3Δ0 ksp1K47D MATα This study 
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Table 4.2. Plasmids used in this study 
 
Short name Description Source 
 pFA6a-GFP(S65T)-HisMX6 [31] 
 pFA6a-kanMX [31] 
pRS406 URA3, Cen, AMP  [37] 
 PKSP1-ksp1K47D This study 
 PKSP1-KSP1 This study 
pLG669-
Z FLO11 6/7 URA3, 2 µ, AMP, pFLO11::LacZ-6/7 [33] 
pPS2037 URA3, 2µ, AMP, PGK1-U1A-PGK1 3' UTR [38] 
pDS7 LEU, 2 µ, AMP, U1A-mCherry This study 
  
126 
 
Table 4.3. Oligonucleotides used in this study 
 
Name Sequence 
DSK009 CCACCATGGCCACCATAATAGTAGTACCAGTGGCCATAAACGGATCCCCGGGTTAATTAA 
DSK010 TTTATTACTATATATTGCTTTTTCTGACGTGCTTCCTTCAGAATTCGAGCTCGTTTAAAC 
DSK024 
AGATCTACTGTGTCTCCGCAACCAGAGTCAAAGTTAAAAGAAACTTC
TGATGCTACTTCTACTGCTACTCCAACTCCTACCCCTTCCACTAATG
ACTCTAAGGCCAGTTCTGAAGAAAA 
DSK025 
TTTTCTTCAGAACTGGCCTTAGAGTCATTAGTGGAAGGGGTAGGAGT
TGGAGTAGCAGTAGAAGTAGCATCAGAAGTTTCTTTTAACTTTGACT
CTGGTTGCGGAGACACAGTAGATCT 
DSK028 ATTAAAATCTAATTCTTCGTTGCCTCCAAAACCGATCAGCAAAACCCCTTCGGCCGAGAGTGCACCATACCACAGC 
DSK029 CTTGAGATATGTTGCTGCCACTTCTTCTAGATTCTGATTTCCCTGCAGAAATCTGTTAGTTTTGCTGGCCGCATC 
DSK034 
CTCCTACTACACAGATTTCTGCAGGGAAATCAGAATCTAGAAGAAGT
GGCAGCAACATAGCTCAAGGCCAATCATCTACCGGCCATACCACGA
GATCTAGTACTTCATTGAGAAGACGTA 
DSK035 
TACGTCTTCTCAATGAAGTACTAGATCTCGTGGTATGGCCGGTAGAT
GATTGGCCTTGAGCTATGTTGCTGCCACTTCTTCTAGATTCTGATTT
CCCTGCAGAAATCTGTGTAGTAGGAG 
DSK096 TATGTATCATTGGCTAAAGATGTTAGAGAGAAAAGATTGGTTGCAGAGAGAGTGCACCATACCACAGC 
DSK097 GTCCTGAGGCCCATCGTACTGGCCGTCATCTTCTAATTTGAAAATTTAGTTTTGCTGGCCGCATC 
DSK100 
GGTTCATATGGTTATGTATCATTGGCTAAAGATGTTAGAGAGAAAAG
ATTGGTTGCAGTCGACTACATTTTCAAATTAGAAGATGACGGCCAGT
ACGATGGGCCTCAGGACGACGAAAAT 
DSK101 
ATTTTCGTCGTCCTGAGGCCCATCGTACTGGCCGTCATCTTCTAATT
TGAAAATGTAGTCGACTGCAACCAATCTTTTCTCTCTAACATCTTTAG
CCAATGATACATAACCATATGAACC 
DSK114 TCCTCGCCCTTGCTCACCATGAGTTCTTCTCCTTTGCTAGCC 
DSK115 TGGACGAGCTGTACAAGTAGCCTCGAGGGGGGGCC 
DSK116 CTAGCAAAGGAGAAGAACTCATGGTGAGCAAGGGCGAG 
DSK117 TACCGGGCCCCCCCTCGAGGCTACTTGTACAGCTCGTCCATG 
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DSK118 AAAGAAACCGTAAATTTGGACGTAACTGAAGATGATAAACAAAAGCGGATCCCCGGGTTAATTAA 
DSK119 GTGTATATACTTTGTCGATAATAAGGTGTACCCTGCTTGCTACGTGAATTCGAGCTCGTTTAAAC 
DSK121 
TCTAATTCTTCGTTGCCTCCAAAACCGATCAGCAAAACCCCTTCGGC
CAAGACTGTTGACCCTACTACACAGATTTCTGCAGGGAAATCAGAAT
CTAGAAGAAGTGGCAGCAACATATCT 
DSK122 
AGATATGTTGCTGCCACTTCTTCTAGATTCTGATTTCCCTGCAGAAAT
CTGTGTAGTAGGGTCAACAGTCTTGGCCGAAGGGGTTTTGCTGATC
GGTTTTGGAGGCAACGAAGAATTAGA 
oCK0259 AAACTGACATCCTCAGTCACGGAAGTAATTAAAGGAGTTCATTACATTGAAACAATTTAGCTTGCCTCGTCCCCG 
oCK0260 AAAGTGCATGAATTTATTACTATATATTGCTTTTTCTGACGTGCTTCCTTCACGAGCTCGTTTAAACTGGATGGC 
oCK0263 TCACTGCCTCACACCCCATCCTAAATATCCCACAAGATCCTCGACTAATACAAGAATTAGCTTGCCTCGTCCCCG 
oCK0264 CACAACTGTGTATATACTTTGTCGATAATAAGGTGTACCCTGCTTGCTACGTCGAGCTCGTTTAAACTGGATGGC 
oCK0265 CTTCTTGCTCATAAATAAGCAAGGTAAGAGGACAACTGTAATTACCTATTACAATATTAGCTTGCCTCGTCCCCG 
oCK0266 AACATCCTTGTATCCAAGTGACATTTTCGATACTTAACATGATCTATTCATGCGAGCTCGTTTAAACTGGATGGC 
oCK0327 TTTCAAATACAAAACAAAAAGACACGTAAAGTTAGTGCAATATTTTTTTCTTACAATTTTTTGAAACTCGTTAGCTTGCCTCGTCCCCG 
oCK0327 TTTCAAATACAAAACAAAAAGACACGTAAAGTTAGTGCAATATTTTTTTCTTACAATTTTTTGAAACTCGTTAGCTTGCCTCGTCCCCG 
oCK0328 GAAAAAAGCTAAAAATGCATTTCAGAAGGGAAGAAAATAATAAGCAACATAACAGAGGGAATAGGTGCGCCGAGCTCGTTTAAACTGGATGGC 
oCK0328 GAAAAAAGCTAAAAATGCATTTCAGAAGGGAAGAAAATAATAAGCAACATAACAGAGGGAATAGGTGCGCCGAGCTCGTTTAAACTGGATGGC 
oCK0428 CAGTGAAGGTTCATATGGTTATGTATCATTGGCTAAAGATGTTAGAGAGAAAAGAGAGAGTGCACCATACCACAGC 
oCK0429 TATCACAATCATTTTCGTCGTCCTGAGGCCCATCGTACTGGCCGTCATCTTCTAATTAGTTTTGCTGGCCGCATC 
oCK0430 
ATCATTTTCGTCGTCCTGAGGCCCATCGTACTGGCCGTCATCTTCTA
ATTTGAAAATGTAATCGACTGCAACCAATCTTTTCTCTCTAACATCTT
TAGCCAATGATACATAACCATATGA 
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oCK0431 
TCATATGGTTATGTATCATTGGCTAAAGATGTTAGAGAGAAAAGATT
GGTTGCAGTCGATTACATTTTCAAATTAGAAGATGACGGCCAGTACG
ATGGGCCTCAGGACGACGAAAATGAT 
oCK0448 ACAGTCTCAGGAAAGATCTACTGTGTCTCCGCAACCAGAGTCAAAGTTAAAAGAAGAGAGTGCACCATACCACAGC 
oCK0449 CAGCTTCAGATATATTTTCTTCAGAACTGGCCTTAGAGTCATTAGTGGAAGGGGTTTAGTTTTGCTGGCCGCATC 
oCK0450 
CAGGAAAGATCTACTGTGTCTCCGCAACCAGAGTCAAAGTTAAAAGA
AACTTCTGATGCTACTTCTACTTCTACTCCAACTCCTACCCCTTCCAC
TAATGACTCTAAGGCCAGTTCTGAA 
oCK0451 
TTCAGAACTGGCCTTAGAGTCATTAGTGGAAGGGGTAGGAGTTGGA
GTAGAAGTAGAAGTAGCATCAGAAGTTTCTTTTAACTTTGACTCTGG
TTGCGGAGACACAGTAGATCTTTCCTG 
oCK0452 
ACTGTGTCTCCGCAACCAGAGTCAAAGTTAAAAGAAACTTCTGATTC
TACTTCTACTGCTACTCCAACTCCTACCCCTTCCACTAATGACTCTAA
GGCCAGTTCTGAAGAAAATATATCT 
oCK0453 
AGATATATTTTCTTCAGAACTGGCCTTAGAGTCATTAGTGGAAGGGG
TAGGAGTTGGAGTAGCAGTAGAAGTAGAATCAGAAGTTTCTTTTAAC
TTTGACTCTGGTTGCGGAGACACAGT 
oCK0656 CCAGCAGCCAGTTGCATCTTCCACAGTAAACTCGAATAAGAGCTCCACTGATGAGAGTGCACCATACCACAGC 
oCK0657 GAATTGATCTGTCTTGGCGTGGTTGTCATCGATGGTTTAGAGATAACGGGTTAGTTTTGCTGGCCGCATC 
oCK0658 
CAGCCAGTTGCATCTTCCACAGTAAACTCGAATAAGAGCTCCACTGA
TATACGAAGGGCTGCACCAGTGTCCACTCCCGTTATCTCTAAACCAT
CGATGACAACCACGCCAAGACAGATC 
oCK0659 
GATCTGTCTTGGCGTGGTTGTCATCGATGGTTTAGAGATAACGGGA
GTGGACACTGGTGCAGCCCTTCGTATATCAGTGGAGCTCTTATTCG
AGTTTACTGTGGAAGATGCAACTGGCTG 
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Table 4.4. Table of hyperphosphorylated peptides 
 
Systematic 
name 
Common 
Name Peptide H/L Ratio Significance 
YBL032W HEK2 KLEAAEGDATVVT(ph)ER 3.4028 0.018291 
YBL067C UBP13 KKEELPIADDLDTAIDDSFVS(ph)NTPIK 2.7758 0.041463 
YDL042C SIR2 VQDLGS(ph)AISVTNVEDPLAKK 11.299 1.39E-05 
YDL051W LHP1 RNS(ph)FAVIEFTPEVLDR 6.0467 0.00097901 
YDL131W LYS21 DFHAELS(ph)TPLLKPVNK 2.6429 0.049668 
YDL182W LYS20 NFHAEVS(ph)TPQVLSAK 5.8667 0.0011687 
YDL182W LYS20 NFHAEVST(ph)PQVLSAK 5.5976 0.0015308 
YDL182W LYS20 KNDS(ph)DVPELATIPAAK 4.7171 0.0038843 
YDR001C NTH1 RGS(ph)EDDTYSSSQGNR 3.42 0.017899 
YDR037W KRS1 KKT(ph)DLFADLDPSQYFETR 5.057 0.0026869 
YDR135C YCF1 RASDAT(ph)LGSIDFGDDENIAK 2.8938 0.035396 
YDR310C SUM1 TAGDDGALDQTENTSIS(ph)PK 2.7074 0.045487 
YEL046C GLY1 S(ph)ESTEVDVDGNAIR 4.338 0.0059462 
YEL046C GLY1 SES(ph)TEVDVDGNAIR 3.7774 0.011509 
YEL046C GLY1 SEST(ph)EVDVDGNAIR 3.7555 0.011818 
YER026C CHO1 DENDGY(ph)AS(ph)DEVGGTLS(ph)R 2.7463 0.043148 
YGL173C XRN1 KGEIKPSSGTNSTECQS(ph)PK 3.7551 0.011824 
YGR093W DRN1 RPLETETENS(ph)FDGDK 5.0033 0.0028459 
YGR178C PBP1 TVS(ph)PTTQISAGK 3.5367 0.015466 
YHR146W CRP1 REST(ph)EGVLDGSK 2.8726 0.036411 
YJL082W IML2 TNDS(ph)SLLPGYMDSATLLHPGK 4.2795 0.0063592 
YJR076C CDC11 TEALS(ph)GESVAAESIRPNLTK 70.709 6.80E-14 
YJR076C CDC11 TEALSGES(ph)VAAESIRPNLTK 39.086 9.92E-11 
YJR076C CDC11 T(ph)EALSGESVAAESIRPNLTK 17.243 4.10E-07 
YKL054C DEF1 KTES(ph)PLENVAELKK 4.2887 0.0062922 
YKL054C DEF1 T(ph)ES(ph)PLENVAELKK 3.9251 0.0096348 
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YLR196W PWP1 ATLEEAEGES(ph)GVEDDAATGSSNK 2.7351 0.04381 
YLR323C CWC24 RPS(ph)DDNELVLNMSGK 2.7019 0.045824 
YLR330W CHS5 DATESVAVEPS(ph)NEDVKPEEK 3.2382 0.022557 
YMR240C CUS1 HTAEDELEDTPS(ph)DGIEEHLSAR 2.6761 0.047462 
YNL118C DCP2 NPISSTVSSNQQS(ph)PK 3.0876 0.027411 
YNL118C DCP2 NPISSTVSS(ph)NQQSPK 2.8689 0.03659 
YNL166C BNI5 Y(ph)DSPVSSPITSASELGSIAK 2.8891 0.035618 
YOR042W CUE5 VVAETTYIDT(ph)PDT(ph)ETK 4.1676 0.0072385 
YOR042W CUE5 VVAETTYIDT(ph)PDT(ph)ET(ph)K 3.9602 0.0092396 
YOR153W PDR5 MLQESS(ph)EEES(ph)DT(ph)YGEIGLSK 2.6716 0.047758 
YOR198C BFR1 VVADDLVLVT(ph)PK 5.7514 0.001311 
YOR217W RFC1 KMPVSNVIDVS(ph)ET(ph)PEGEK 5.0739 0.0026388 
YOR220W RCN2 NKPLLS(ph)INTDPGVTGVDSSSLNK 3.5556 0.015108 
YOR220W RCN2 NKPLLSINT(ph)DPGVTGVDSSSLNK 3.2771 0.021459 
YPL058C PDR12 HLSNILS(ph)NEEGIER 3.4782 0.016639 
YPR137C-B   EVHTNQDPLDVS(ph)ASK 3.3102 0.020571 
YPR137C-B   EVHTNQDPLDVSASKT(ph)EECEK 2.8097 0.039612 
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Table 4.5. Table of hypophosphorylated peptides 
 
Systematic 
name 
Common 
Name Peptide H/L Ratio Significance 
Q0060 AI3 KINRNY(ph)VLWT(ph)IHDLK 0.0013459 1.08E-26 
YAL022C FUN26 KPILAVPEPALADT(ph)HSEEISR 0.23787 0.0094654 
YAL035W FUN12 S(ph)TPAAT(ph)PAAT(ph)PT(ph)PSSASPNKK 0.2656 0.0069482 
YAL035W FUN12 S(ph)T(ph)PAAT(ph)PAATPTPSSASPNKK 0.4093 0.043466 
YAL038W CDC19 T(ph)SIIGTIGPK 0.28288 0.019251 
YAL038W CDC19 RTS(ph)IIGTIGPK 0.35123 0.042438 
YAL038W CDC19 LTS(ph)LNVVAGSDLR 0.36559 0.030004 
YAR002W NUP60 RAS(ph)ATVPSAPYR 0.46713 
Not 
calculated 
(NC) 
YBL051C PIN4 SLS(ph)GLDLQNQNK 0.33435 0.035781 
YBR001C NTH2 RGS(ph)EDDSFLSSQGNR 0.28923 0.010376 
YBR025C OLA1 S(ph)T(ph)FFQAITR 0.16702 0.00055233 
YBR054W YRO2 KAQEEEEDVATDS(ph)E 0.28881 0.010307 
YBR081C SPT7 VGAENDGDS(ph)S(ph)LFLR 0.23971 0.0041781 
YBR169C SSE2 S(ph)T(ph)PSLVGFGPR 0.36242 0.027288 
YBR255W MTC4 IT(ph)RS(ph)S(ph)IPLIPS(ph)VSNEQQK 0.0024065 0.0024065 
YBR255W MTC4 IT(ph)RS(ph)S(ph)IPLIPS(ph)VSNEQQK 0.015406 0.015406 
YCL052C PBN1 VT(ph)VLY(ph)NAPEDIGNHMR 0.47394 NC  
YCR034W ELO2 NVPT(ph)PS(ph)PS(ph)PKPQHR 0.42681 0.079108 
YDL019C OSH2 S(ph)REDLS(ph)IAEDLNQVSKPLLK 0.39586  NC 
YDL058W USO1 EAT(ph)ETSSAVQTK 0.15064 0.00028981 
YDL195W SEC31 APS(ph)SVSMVSPPPLHK 0.47458 0.10725 
YDL195W SEC31 APSSVS(ph)MVSPPPLHK 0.48265 0.11232 
YDL223C HBT1 S(ph)ISGGTFGFR 0.1964 0.0089925 
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YDR001C NTH1 RGS(ph)EDDTYSSSQGNR 0.16791 0.00057059 
YDR005C MAF1 RDS(ph)NSFWEQK 0.29653 0.038968 
YDR037W KRS1 KTDLFADLDPS(ph)QYFETR 0.1385 0.00016771 
YDR135C YCF1 RAS(ph)DAT(ph)LGSIDFGDDENIAK 0.49411 NC  
YDR171W HSP42 KS(ph)S(ph)S(ph)FAHLQAPS(ph)PIPDPLQVSKPETR 0.19955 0.004294 
YDR171W HSP42 DKS(ph)EAPKEEAGETNK 0.30152 0.012529 
YDR293C SSD1 SST(ph)INNDSDSLSSPTK 0.46786 0.1031 
YDR303C RSC3 KLSEDGVT(ph)DGDGKPIPESER 0.47433 0.1071 
YDR432W NPL3 NLPEGCS(ph)WQDLK 0.28623 0.0098887 
YDR432W NPL3 ENS(ph)LETTFSSVNTR 0.38084 0.37625 
YER052C HOM3 KGESTPPHPPENLS(ph)SSFYEK 0.36413 0.027804 
YER052C HOM3 TNT(ph)SNQFEHAIDER 0.39597 0.034153 
YER052C HOM3 KGES(ph)TPPHPPENLSSSFYEK 0.42225 0.048665 
YER052C HOM3 KGESTPPHPPENLSS(ph)SFYEK 0.4318  NC 
YER052C HOM3 KGEST(ph)PPHPPENLSSSFYEK 0.44344  NC 
YER052C HOM3 KGESTPPHPPENLSSS(ph)FYEK 0.46309 NC  
YER052C HOM3 KGESTPPHPPENLSSSFY(ph)EK 0.4715 NC  
YER083C GET2 TTPPAS(ph)VHSAT(ph)PDIK 0.12809 9.90E-05 
YER093C TSC11 NITSSSPS(ph)TITNESSKRNK 0.032525 1.59E-08 
YER176W ECM32 LIYEEGEPLT(ph)R 0.33593 0.057032 
YFL014W HSP12 GKDNAEGQGES(ph)LADQAR 0.17646 0.00076949 
YFL021W GAT1 RNPSPSIVKPGS(ph)R 0.26104 0.0063899 
YFR014C CMK1 VCSS(ph)DSDLPGSDIK 0.28453 0.0095195 
YFR017C IGD1 ERES(ph)S(ph)IGEHAPGAER 0.19861 0.056558 
YFR017C IGD1 RST(ph)NYMDALNSR 0.21785 0.013409 
YFR017C IGD1 ERESS(ph)IGEHAPGAER 0.21964 0.01395 
YFR053C HXK1 KGS(ph)MADVPK 0.214 0.0059332 
YGL008C PMA1 TDTSSSSSSSSASS(ph)VSAHQPTQEKPAK 0.21985 0.0026675 
YGL009C LEU1 DQDQSS(ph)PKVEVTSEDEK 0.31283 0.028169 
133 
 
YGL009C LEU1 DQDQS(ph)SPKVEVTSEDEK 0.33477 0.03594 
YGL009C LEU1 ELES(ph)AAY(ph)DHAEPVQPEDAPQDIANDELK 0.41354 0.07192 
YGL009C LEU1 VEVTS(ph)EDEK 0.41956 0.075145 
YGL009C LEU1 VEVT(ph)SEDEKELESAAYDHAEPVQPEDAPQDIANDELK 0.4678 0.1031 
YGL061C DUO1 S(ph)T(ph)NS(ph)ILDSWINIHS(ph)QAGYIHK 0.00073996 2.39E-31 
YGR086C PIL1 ALLELLDDSPVTPGETRPAYDGY(ph)EAS(ph)K 0.49393 0.11953 
YGR116W SPT6 VGDEGNAAESESDNVAAS(ph)R 0.48376 0.11302 
YGR162W TIF4631 LKETSDS(ph)TST(ph)S(ph)T(ph)PTPTPSTNDSK 0.30816 0.013804 
YGR178C PBP1 S(ph)GS(ph)NIS(ph)QGQSSTGHTTR 0.30722 0.043544 
YGR178C PBP1 S(ph)GS(ph)NISQGQSSTGHTTR 0.33652 0.057327 
YGR240C PFK1 ASS(ph)DASDLLR 0.43935 NC  
YGR267C FOL2 HET(ph)PLNIRPTS(ph)PYTLNPPVER 0.24449 0.010641 
YGR280C PXR1 SSES(ph)ASNIPDAVNTR 0.30916 0.044402 
YHL007C STE20 RAT(ph)PVS(ph)T(ph)PVISKPSMTTTPR 0.23046 0.016 
YHR064C SSZ1 EENAEEDDES(ph)EWSDDEPEVVR 0.47019 NC  
YHR073W OSH3 RSS(ph)QHSHSSSNGSDNKR 0.09827 8.43E-05 
YHR099W TRA1 KEDINDS(ph)PDVEMTESDK 0.4822 0.11204 
YHR135C YCK1 TPEQHPNDDNSS(ph)LAASHK 0.31692 0.015607 
YHR195W NVJ1 DCSSSS(ph)EVESQSK 0.37556 0.031399 
YIL107C PFK26 RYS(ph)VIPTAPPS(ph)AR 0.20317 0.010271 
YIL107C PFK26 SS(ph)FASDFLSR 0.21215 0.0021954 
YIL107C PFK26 S(ph)S(ph)FASDFLSR 0.28489 0.034271 
YIL135C VHS2 RPS(ph)TIGLDR 0.25572 0.0057768 
YIR003W AIM21 HPESS(ph)LEELQK 0.49275 0.11878 
YJL055W   GAT(ph)PISEEYGETTIVPDMHTR 0.40687 0.06842 
YJL057C IKS1 RAS(ph)AGVESESSR 0.38565 0.034781 
YJL080C SCP160 KPT(ph)PLPSLK 0.27114 0.0076709 
YJL141C YAK1 TVYTY(ph)IQSR 0.42105  NC 
YJR076C CDC11 TEALSGESVAAES(ph)IRPNLT(ph)K 0.11266 0.0001977 
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YKL035W UGP1 DVTLRGTVIIVCS(ph)DGHK 0.0014192 2.68E-26 
YKL186C MTR2 MGQDATVPIQPNNT(ph)GNR 0.37625  NC 
YKR098C UBP11 FDGSLHEIPNELTKPTNDNS(ph)KEDIVR 0.27347 0.016852 
YLL018C DPS1 AVEES(ph)AEPAQVILGEDGKPLSK 0.34855 0.041343 
YLL043W FPS1 TTGAQTNMESNES(ph)PR 0.33274 0.035176 
YLR044C PDC1 NPVILADACCS(ph)R 0.47529  NC 
YLR058C SHM2 LITSHLVDTDPEVDS(ph)IIKDEIER 0.25724 0.0059479 
YLR079W SIC1 S(ph)QES(ph)EDEEDIIINPVR 0.37671  NC 
YLR133W CKI1 T(ph)IS(ph)IESDVSNITDDDDLR 0.45956  NC 
YLR219W MSC3 RLS(ph)TSS(ph)AAPPTSR 0.10497 0.00051354 
YLR220W CCC1 NSAQDLENS(ph)PM(ox)SVGK 0.37681 0.031807 
YLR330W CHS5 SEPVGT(ph)PNIEENK 0.49899 0.12282 
YLR399C BDF1 WADRPNLDDYDS(ph)DEDSR 0.47849 0.1097 
YML100W TSL1 S(ph)AT(ph)RS(ph)PSAFNR 0.23612 0.0038676 
YMR012W CLU1 DDVKPELANKS(ph)VDELLTFIEGDSSNSK 0.48803 NC  
YMR074C   KDFS(ph)EDLNSFDK 0.46394 0.1007 
YMR104C YPK2 INTNET(ph)LPSSLSSPK 0.494 0.11958 
YMR165C PAH1 RAS(ph)SAAATSIDK 0.47664  NC 
YMR196W   IGGTHSGLT(ph)PQSSISSDK 0.35338 0.024652 
YMR240C CUS1 HTAEDELEDT(ph)PSDGIEEHLSAR 0.43473 0.083538 
YMR291W TDA1 KNS(ph)T(ph)FVLDPKPPK 0.16011 0.001439 
YNL015W PBI2 HNDVIENVEEDKEVHT(ph)N 0.21859 0.00653 
YNL101W AVT4 RAQSTVLNS(ph)NPFYSRK 0.18975 0.0033778 
YNL113W RPC19 HIQEEEEQDVDMT(ph)GDEEQEEEPDREK 0.17502 0.00073275 
YNL121C TOM70 FGDIDT(ph)ATAT(ph)PT(ph)ELSTQPAK 0.12446 0.00035769 
YNL173C MDG1 DTSTSADAEAS(ph)EDQNKEPLSK 0.25936 0.013607 
YNL175C NOP13 DAQGEES(ph)TINT(ph)PTGDESGEVVK 0.469 0.10379 
YNL212W VID27 SSLTAS(ph)ADDLK 0.31118 0.014411 
YNL231C PDR16 NKS(ph)EDDLKPLEEEEK 0.13005 0.00012349 
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YNL248C RPA49 IDSDKLTDS(ph)AIDIVDSVR 0.2025 0.0045994 
YNL267W PIK1 SST(ph)PTSPIDLIDPIK 0.27543 0.030682 
YNL304W YPT11 S(ph)GAFGRS(ph)GSSGS(ph)S(ph)TVIEPSNIK 0.27393 0.016964 
YNR012W URK1 SS(ph)S(ph)FISILDDETR 0.42512 NC  
YOL004W SIN3 VT(ph)T(ph)PMGTTTVNNNISPSGR 0.31864 0.030126 
YOL016C CMK2 NMYSLGDDGDNDIEENS(ph)LNESLLDGVTHSLDDLR 0.38771 0.035478 
YOL062C APM4 SSSFLGQGDS(ph)TSDFYDNNK 0.040522 5.57E-09 
YOL109W ZEO1 NEAT(ph)PEAEQVK 0.48747 0.0065105 
YOL145C CTR9 TLSDS(ph)DEDDDDVVK 0.35743 0.02554 
YOL151W GRE2 ETIDDTAS(ph)QILK 0.31223 0.014753 
YOR018W ROD1 NFVDDS(ph)EEDVIFQR 0.17061 0.0050562 
YOR052C TMC1 S(ph)DS(ph)GTVLGAIPLNSR 0.31177 0.04521 
YOR109W INP53 S(ph)VSAPAPSTSK 0.29675 0.0117 
YOR205C GEP3 Y(ph)AIPPFIGS(ph)IEIVLK 0.0040536 3.83E-19 
YOR239W ABP140 TAEKPLETNLPKPETNEEDEEEGS(ph)MSENK 0.45399 0.094716 
YOR260W GCD1 DSTAATS(ph)GDKLNELVNSALDSTVINEFMQHSTR 0.21058 0.0021082 
YOR273C TPO4 THT(ph)QPVPASFDR 0.30206 0.041304 
YPL004C LSP1 ALLELLDDSPVT(ph)PGEARPAYDGYEASR 0.2247 0.0029868 
YPL116W HOS3 TVEDIT(ph)IDDISR 0.29238 0.037258 
YPL150W   RVS(ph)SLLVEDGGNPTA 0.49401 NC  
YPL153C RAD53 DFS(ph)IIDEVAGQGAFATVKK 0.17558 0.00074691 
YPL160W CDC60 NFDNVPAEEEEIKEET(ph)PAEKDHEDVT(ph)K 0.26174 0.014125 
YPL160W CDC60 NFDNVPAEEEEIKEET(ph)PAEK 0.37355 0.052141 
YPL263C KEL3 TKS(ph)FELCEDR 0.3563 0.025487 
YPR019W MCM4 NNS(ph)QNLSQGEGNIR 0.41548 0.045909 
YPR093C ASR1 NSMIFAGELRDKHS(ph)VK 0.0019333 4.59E-24 
YPR160W GPH1 RLT(ph)GFLPQEIK 0.36207 0.047024 
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Table 4.6. Table of novel phosphorylation sites 
 
Systematic 
name 
Common 
Name Peptide H/L Ratio Significance 
Q0060 AI3 KINRNY(ph)VLWT(ph)IHDLK 0.0013459 1.08E-26 
YAL022C FUN26 KPILAVPEPALADT(ph)HSEEISR 0.23787 0.0094654 
YBL032W HEK2 KLEAAEGDATVVT(ph)ER 3.4028 0.018291 
YBL067C UBP13 KKEELPIADDLDTAIDDSFVS(ph)NTPIK 2.7758 0.041463 
YDL019C OSH2 S(ph)REDLS(ph)IAEDLNQVSKPLLK 0.39586  NC 
YDL042C SIR2 VQDLGS(ph)AISVTNVEDPLAKK 11.299 1.39E-05 
YDR171W HSP42 KS(ph)S(ph)S(ph)FAHLQAPS(ph)PIPDPLQVSKPETR 0.19955 0.004294 
YDR303C RSC3 KLSEDGVT(ph)DGDGKPIPESER 0.47433 0.1071 
YER026C CHO1 DENDGY(ph)AS(ph)DEVGGTLS(ph)R 2.7463 0.043148 
YER052C HOM3 KGESTPPHPPENLS(ph)SSFYEK 0.36413 0.027804 
YER052C HOM3 TNT(ph)SNQFEHAIDER 0.39597 0.034153 
YER052C HOM3 KGES(ph)TPPHPPENLSSSFYEK 0.42225 0.048665 
YER052C HOM3 KGESTPPHPPENLSS(ph)SFYEK 0.4318 NC  
YER052C HOM3 KGESTPPHPPENLSSS(ph)FYEK 0.46309 NC  
YER052C HOM3 KGESTPPHPPENLSSSFY(ph)EK 0.4715 NC  
YER093C TSC11 NITSSSPS(ph)TITNESSKRNK 0.032525 1.59E-08 
YGL009C LEU1 ELES(ph)AAY(ph)DHAEPVQPEDAPQDIANDELK 0.41354 0.07192 
YGL061C DUO1 S(ph)T(ph)NS(ph)ILDSWINIHS(ph)QAGYIHK 0.00073996 2.39E-31 
YGR086C PIL1 ALLELLDDSPVTPGETRPAYDGY(ph)EAS(ph)K 0.49393 0.11953 
YGR116W SPT6 VGDEGNAAESESDNVAAS(ph)R 0.48376 0.11302 
YGR162W TIF4631 LKETSDS(ph)TST(ph)S(ph)T(ph)PTPTPSTNDSK 0.30816 0.013804 
YGR267C FOL2 HET(ph)PLNIRPTS(ph)PYTLNPPVER 0.24449 0.010641 
YHR073W OSH3 RSS(ph)QHSHSSSNGSDNKR 0.09827 8.43E-05 
YJL055W   GAT(ph)PISEEYGETTIVPDMHTR 0.40687 0.06842 
YJR076C CDC11 TEALSGESVAAES(ph)IRPNLT(ph)K 0.11266 0.0001977 
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YJR076C CDC11 T(ph)EALSGESVAAESIRPNLTK 17.243 4.10E-07 
YJR076C CDC11 TEALSGES(ph)VAAESIRPNLTK 39.086 9.92E-11 
YJR076C CDC11 TEALS(ph)GESVAAESIRPNLTK 70.709 6.80E-14 
YKL035W UGP1 DVTLRGTVIIVCS(ph)DGHK 0.0014192 2.68E-26 
YKL054C DEF1 T(ph)ES(ph)PLENVAELKK 3.9251 0.0096348 
YKR098C UBP11 FDGSLHEIPNELTKPTNDNS(ph)KEDIVR 0.27347 0.016852 
YLR133W CKI1 T(ph)IS(ph)IESDVSNITDDDDLR 0.45956 NC  
YLR330W CHS5 SEPVGT(ph)PNIEENK 0.49899 0.12282 
YMR104C YPK2 INTNET(ph)LPSSLSSPK 0.494 0.11958 
YMR240C CUS1 HTAEDELEDT(ph)PSDGIEEHLSAR 0.43473 0.083538 
YMR240C CUS1 HTAEDELEDTPS(ph)DGIEEHLSAR 2.6761 0.047462 
YNL101W AVT4 RAQSTVLNS(ph)NPFYSRK 0.18975 0.0033778 
YNL121C TOM70 FGDIDT(ph)ATAT(ph)PT(ph)ELSTQPAK 0.12446 0.00035769 
YNL173C MDG1 DTSTSADAEAS(ph)EDQNKEPLSK 0.25936 0.013607 
YNL175C NOP13 DAQGEES(ph)TINT(ph)PTGDESGEVVK 0.469 0.10379 
YNL248C RPA49 IDSDKLTDS(ph)AIDIVDSVR 0.2025 0.0045994 
YNL304W YPT11 S(ph)GAFGRS(ph)GSSGS(ph)S(ph)TVIEPSNIK 0.27393 0.016964 
YOR153W PDR5 MLQESS(ph)EEES(ph)DT(ph)YGEIGLSK 2.6716 0.047758 
YOR205C GEP3 Y(ph)AIPPFIGS(ph)IEIVLK 0.0040536 3.83E-19 
YOR220W RCN2 NKPLLS(ph)INTDPGVTGVDSSSLNK 3.5556 0.015108 
YPL160W CDC60 NFDNVPAEEEEIKEET(ph)PAEKDHEDVT(ph)K 0.26174 0.014125 
YPR093C ASR1 NSMIFAGELRDKHS(ph)VK 0.0019333 4.59E-24 
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Table 4.7. Table of differentially phosphorylated peptides 
 
Systematic 
name 
Common 
Name Peptide H/L Ratio Significance 
Q0060 AI3 KINRNY(ph)VLWT(ph)IHDLK 0.0013459 1.08E-26 
YAL022C FUN26 KPILAVPEPALADT(ph)HSEEISR 0.23787 0.0094654 
YAL035W FUN12 S(ph)TPAAT(ph)PAAT(ph)PT(ph)PSSASPNKK 0.2656 0.0069482 
YAL035W FUN12 S(ph)T(ph)PAAT(ph)PAATPTPSSASPNKK 0.4093 0.043466 
YAL038W CDC19 T(ph)SIIGTIGPK 0.28288 0.019251 
YAL038W CDC19 RTS(ph)IIGTIGPK 0.35123 0.042438 
YAL038W CDC19 LTS(ph)LNVVAGSDLR 0.36559 0.030004 
YAR002W NUP60 RAS(ph)ATVPSAPYR 0.46713  NC 
YBL032W HEK2 KLEAAEGDATVVT(ph)ER 3.4028 0.018291 
YBL051C PIN4 SLS(ph)GLDLQNQNK 0.33435 0.035781 
YBL067C UBP13 KKEELPIADDLDTAIDDSFVS(ph)NTPIK 2.7758 0.041463 
YBR001C NTH2 RGS(ph)EDDSFLSSQGNR 0.28923 0.010376 
YBR025C OLA1 S(ph)T(ph)FFQAITR 0.16702 0.00055233 
YBR054W YRO2 KAQEEEEDVATDS(ph)E 0.28881 0.010307 
YBR081C SPT7 VGAENDGDS(ph)S(ph)LFLR 0.23971 0.0041781 
YBR169C SSE2 S(ph)T(ph)PSLVGFGPR 0.36242 0.027288 
YBR255W MTC4 IT(ph)RS(ph)S(ph)IPLIPS(ph)VSNEQQK 0.0024065 0.0024065 
YBR255W MTC4 IT(ph)RS(ph)S(ph)IPLIPS(ph)VSNEQQK 0.015406 0.015406 
YCL052C PBN1 VT(ph)VLY(ph)NAPEDIGNHMR 0.47394  NC 
YCR034W ELO2 NVPT(ph)PS(ph)PS(ph)PKPQHR 0.42681 0.079108 
YDL019C OSH2 S(ph)REDLS(ph)IAEDLNQVSKPLLK 0.39586 NC  
YDL042C SIR2 VQDLGS(ph)AISVTNVEDPLAKK 11.299 1.39E-05 
YDL051W LHP1 RNS(ph)FAVIEFTPEVLDR 6.0467 0.00097901 
YDL058W USO1 EAT(ph)ETSSAVQTK 0.15064 0.00028981 
YDL131W LYS21 DFHAELS(ph)TPLLKPVNK 2.6429 0.049668 
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YDL182W LYS20 KNDS(ph)DVPELATIPAAK 4.7171 0.0038843 
YDL182W LYS20 NFHAEVST(ph)PQVLSAK 5.5976 0.0015308 
YDL182W LYS20 NFHAEVS(ph)TPQVLSAK 5.8667 0.0011687 
YDL195W SEC31 APS(ph)SVSMVSPPPLHK 0.47458 0.10725 
YDL195W SEC31 APSSVS(ph)MVSPPPLHK 0.48265 0.11232 
YDL223C HBT1 S(ph)ISGGTFGFR 0.1964 0.0089925 
YDR001C NTH1 RGS(ph)EDDTYSSSQGNR 0.16791 0.00057059 
YDR001C NTH1 RGS(ph)EDDTYSSSQGNR 3.42 0.017899 
YDR005C MAF1 RDS(ph)NSFWEQK 0.29653 0.038968 
YDR037W KRS1 KTDLFADLDPS(ph)QYFETR 0.1385 0.00016771 
YDR037W KRS1 KKT(ph)DLFADLDPSQYFETR 5.057 0.0026869 
YDR135C YCF1 RAS(ph)DAT(ph)LGSIDFGDDENIAK 0.49411  NC 
YDR135C YCF1 RASDAT(ph)LGSIDFGDDENIAK 2.8938 0.035396 
YDR171W HSP42 KS(ph)S(ph)S(ph)FAHLQAPS(ph)PIPDPLQVSKPETR 0.19955 0.004294 
YDR171W HSP42 DKS(ph)EAPKEEAGETNK 0.30152 0.012529 
YDR293C SSD1 SST(ph)INNDSDSLSSPTK 0.46786 0.1031 
YDR303C RSC3 KLSEDGVT(ph)DGDGKPIPESER 0.47433 0.1071 
YDR310C SUM1 TAGDDGALDQTENTSIS(ph)PK 2.7074 0.045487 
YDR432W NPL3 NLPEGCS(ph)WQDLK 0.28623 0.0098887 
YDR432W NPL3 ENS(ph)LETTFSSVNTR 0.38084 0.37625 
YEL046C GLY1 SEST(ph)EVDVDGNAIR 3.7555 0.011818 
YEL046C GLY1 SES(ph)TEVDVDGNAIR 3.7774 0.011509 
YEL046C GLY1 S(ph)ESTEVDVDGNAIR 4.338 0.0059462 
YER026C CHO1 DENDGY(ph)AS(ph)DEVGGTLS(ph)R 2.7463 0.043148 
YER052C HOM3 KGESTPPHPPENLS(ph)SSFYEK 0.36413 0.027804 
YER052C HOM3 TNT(ph)SNQFEHAIDER 0.39597 0.034153 
YER052C HOM3 KGES(ph)TPPHPPENLSSSFYEK 0.42225 0.048665 
YER052C HOM3 KGESTPPHPPENLSS(ph)SFYEK 0.4318 NC  
YER052C HOM3 KGEST(ph)PPHPPENLSSSFYEK 0.44344 NC  
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YER052C HOM3 KGESTPPHPPENLSSS(ph)FYEK 0.46309 NC  
YER052C HOM3 KGESTPPHPPENLSSSFY(ph)EK 0.4715  NC 
YER083C GET2 TTPPAS(ph)VHSAT(ph)PDIK 0.12809 9.90E-05 
YER093C TSC11 NITSSSPS(ph)TITNESSKRNK 0.032525 1.59E-08 
YER176W ECM32 LIYEEGEPLT(ph)R 0.33593 0.057032 
YFL014W HSP12 GKDNAEGQGES(ph)LADQAR 0.17646 0.00076949 
YFL021W GAT1 RNPSPSIVKPGS(ph)R 0.26104 0.0063899 
YFR014C CMK1 VCSS(ph)DSDLPGSDIK 0.28453 0.0095195 
YFR017C IGD1 ERES(ph)S(ph)IGEHAPGAER 0.19861 0.056558 
YFR017C IGD1 RST(ph)NYMDALNSR 0.21785 0.013409 
YFR017C IGD1 ERESS(ph)IGEHAPGAER 0.21964 0.01395 
YFR053C HXK1 KGS(ph)MADVPK 0.214 0.0059332 
YGL008C PMA1 TDTSSSSSSSSASS(ph)VSAHQPTQEKPAK 0.21985 0.0026675 
YGL009C LEU1 DQDQSS(ph)PKVEVTSEDEK 0.31283 0.028169 
YGL009C LEU1 DQDQS(ph)SPKVEVTSEDEK 0.33477 0.03594 
YGL009C LEU1 ELES(ph)AAY(ph)DHAEPVQPEDAPQDIANDELK 0.41354 0.07192 
YGL009C LEU1 VEVTS(ph)EDEK 0.41956 0.075145 
YGL009C LEU1 VEVT(ph)SEDEKELESAAYDHAEPVQPEDAPQDIANDELK 0.4678 0.1031 
YGL061C DUO1 S(ph)T(ph)NS(ph)ILDSWINIHS(ph)QAGYIHK 0.00073996 2.39E-31 
YGL173C XRN1 KGEIKPSSGTNSTECQS(ph)PK 3.7551 0.011824 
YGR086C PIL1 ALLELLDDSPVTPGETRPAYDGY(ph)EAS(ph)K 0.49393 0.11953 
YGR093W DRN1 RPLETETENS(ph)FDGDK 5.0033 0.0028459 
YGR116W SPT6 VGDEGNAAESESDNVAAS(ph)R 0.48376 0.11302 
YGR162W TIF4631 LKETSDS(ph)TST(ph)S(ph)T(ph)PTPTPSTNDSK 0.30816 0.013804 
YGR178C PBP1 S(ph)GS(ph)NIS(ph)QGQSSTGHTTR 0.30722 0.043544 
YGR178C PBP1 S(ph)GS(ph)NISQGQSSTGHTTR 0.33652 0.057327 
YGR178C PBP1 TVS(ph)PTTQISAGK 3.5367 0.015466 
YGR240C PFK1 ASS(ph)DASDLLR 0.43935   
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YGR267C FOL2 HET(ph)PLNIRPTS(ph)PYTLNPPVER 0.24449 0.010641 
YGR280C PXR1 SSES(ph)ASNIPDAVNTR 0.30916 0.044402 
YHL007C STE20 RAT(ph)PVS(ph)T(ph)PVISKPSMTTTPR 0.23046 0.016 
YHR064C SSZ1 EENAEEDDES(ph)EWSDDEPEVVR 0.47019  NC 
YHR073W OSH3 RSS(ph)QHSHSSSNGSDNKR 0.09827 8.43E-05 
YHR099W TRA1 KEDINDS(ph)PDVEMTESDK 0.4822 0.11204 
YHR135C YCK1 TPEQHPNDDNSS(ph)LAASHK 0.31692 0.015607 
YHR146W CRP1 REST(ph)EGVLDGSK 2.8726 0.036411 
YHR195W NVJ1 DCSSSS(ph)EVESQSK 0.37556 0.031399 
YIL107C PFK26 RYS(ph)VIPTAPPS(ph)AR 0.20317 0.010271 
YIL107C PFK26 SS(ph)FASDFLSR 0.21215 0.0021954 
YIL107C PFK26 S(ph)S(ph)FASDFLSR 0.28489 0.034271 
YIL135C VHS2 RPS(ph)TIGLDR 0.25572 0.0057768 
YIR003W AIM21 HPESS(ph)LEELQK 0.49275 0.11878 
YJL055W   GAT(ph)PISEEYGETTIVPDMHTR 0.40687 0.06842 
YJL057C IKS1 RAS(ph)AGVESESSR 0.38565 0.034781 
YJL080C SCP160 KPT(ph)PLPSLK 0.27114 0.0076709 
YJL082W IML2 TNDS(ph)SLLPGYMDSATLLHPGK 4.2795 0.0063592 
YJL141C YAK1 TVYTY(ph)IQSR 0.42105  NC 
YJR076C CDC11 TEALSGESVAAES(ph)IRPNLT(ph)K 0.11266 0.0001977 
YJR076C CDC11 T(ph)EALSGESVAAESIRPNLTK 17.243 4.10E-07 
YJR076C CDC11 TEALSGES(ph)VAAESIRPNLTK 39.086 9.92E-11 
YJR076C CDC11 TEALS(ph)GESVAAESIRPNLTK 70.709 6.80E-14 
YKL035W UGP1 DVTLRGTVIIVCS(ph)DGHK 0.0014192 2.68E-26 
YKL054C DEF1 T(ph)ES(ph)PLENVAELKK 3.9251 0.0096348 
YKL054C DEF1 KTES(ph)PLENVAELKK 4.2887 0.0062922 
YKL186C MTR2 MGQDATVPIQPNNT(ph)GNR 0.37625  NC 
YKR098C UBP11 FDGSLHEIPNELTKPTNDNS(ph)KEDIVR 0.27347 0.016852 
YLL018C DPS1 AVEES(ph)AEPAQVILGEDGKPLSK 0.34855 0.041343 
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YLL043W FPS1 TTGAQTNMESNES(ph)PR 0.33274 0.035176 
YLR044C PDC1 NPVILADACCS(ph)R 0.47529  NC 
YLR058C SHM2 LITSHLVDTDPEVDS(ph)IIKDEIER 0.25724 0.0059479 
YLR079W SIC1 S(ph)QES(ph)EDEEDIIINPVR 0.37671  NC 
YLR133W CKI1 T(ph)IS(ph)IESDVSNITDDDDLR 0.45956  NC 
YLR196W PWP1 ATLEEAEGES(ph)GVEDDAATGSSNK 2.7351 0.04381 
YLR219W MSC3 RLS(ph)TSS(ph)AAPPTSR 0.10497 0.00051354 
YLR220W CCC1 NSAQDLENS(ph)PM(ox)SVGK 0.37681 0.031807 
YLR323C CWC24 RPS(ph)DDNELVLNMSGK 2.7019 0.045824 
YLR330W CHS5 SEPVGT(ph)PNIEENK 0.49899 0.12282 
YLR330W CHS5 DATESVAVEPS(ph)NEDVKPEEK 3.2382 0.022557 
YLR399C BDF1 WADRPNLDDYDS(ph)DEDSR 0.47849 0.1097 
YML100W TSL1 S(ph)AT(ph)RS(ph)PSAFNR 0.23612 0.0038676 
YMR012W CLU1 DDVKPELANKS(ph)VDELLTFIEGDSSNSK 0.48803 NC  
YMR074C   KDFS(ph)EDLNSFDK 0.46394 0.1007 
YMR104C YPK2 INTNET(ph)LPSSLSSPK 0.494 0.11958 
YMR165C PAH1 RAS(ph)SAAATSIDK 0.47664  NC 
YMR196W   IGGTHSGLT(ph)PQSSISSDK 0.35338 0.024652 
YMR240C CUS1 HTAEDELEDT(ph)PSDGIEEHLSAR 0.43473 0.083538 
YMR240C CUS1 HTAEDELEDTPS(ph)DGIEEHLSAR 2.6761 0.047462 
YMR291W TDA1 KNS(ph)T(ph)FVLDPKPPK 0.16011 0.001439 
YNL015W PBI2 HNDVIENVEEDKEVHT(ph)N 0.21859 0.00653 
YNL101W AVT4 RAQSTVLNS(ph)NPFYSRK 0.18975 0.0033778 
YNL113W RPC19 HIQEEEEQDVDMT(ph)GDEEQEEEPDREK 0.17502 0.00073275 
YNL118C DCP2 NPISSTVSS(ph)NQQSPK 2.8689 0.03659 
YNL118C DCP2 NPISSTVSSNQQS(ph)PK 3.0876 0.027411 
YNL121C TOM70 FGDIDT(ph)ATAT(ph)PT(ph)ELSTQPAK 0.12446 0.00035769 
YNL166C BNI5 Y(ph)DSPVSSPITSASELGSIAK 2.8891 0.035618 
YNL173C MDG1 DTSTSADAEAS(ph)EDQNKEPLSK 0.25936 0.013607 
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YNL175C NOP13 DAQGEES(ph)TINT(ph)PTGDESGEVVK 0.469 0.10379 
YNL212W VID27 SSLTAS(ph)ADDLK 0.31118 0.014411 
YNL231C PDR16 NKS(ph)EDDLKPLEEEEK 0.13005 0.00012349 
YNL248C RPA49 IDSDKLTDS(ph)AIDIVDSVR 0.2025 0.0045994 
YNL267W PIK1 SST(ph)PTSPIDLIDPIK 0.27543 0.030682 
YNL304W YPT11 S(ph)GAFGRS(ph)GSSGS(ph)S(ph)TVIEPSNIK 0.27393 0.016964 
YNR012W URK1 SS(ph)S(ph)FISILDDETR 0.42512  NC 
YOL004W SIN3 VT(ph)T(ph)PMGTTTVNNNISPSGR 0.31864 0.030126 
YOL016C CMK2 NMYSLGDDGDNDIEENS(ph)LNESLLDGVTHSLDDLR 0.38771 0.035478 
YOL062C APM4 SSSFLGQGDS(ph)TSDFYDNNK 0.040522 5.57E-09 
YOL109W ZEO1 NEAT(ph)PEAEQVK 0.48747 0.0065105 
YOL145C CTR9 TLSDS(ph)DEDDDDVVK 0.35743 0.02554 
YOL151W GRE2 ETIDDTAS(ph)QILK 0.31223 0.014753 
YOR018W ROD1 NFVDDS(ph)EEDVIFQR 0.17061 0.0050562 
YOR042W CUE5 VVAETTYIDT(ph)PDT(ph)ET(ph)K 3.9602 0.0092396 
YOR042W CUE5 VVAETTYIDT(ph)PDT(ph)ETK 4.1676 0.0072385 
YOR052C TMC1 S(ph)DS(ph)GTVLGAIPLNSR 0.31177 0.04521 
YOR109W INP53 S(ph)VSAPAPSTSK 0.29675 0.0117 
YOR153W PDR5 MLQESS(ph)EEES(ph)DT(ph)YGEIGLSK 2.6716 0.047758 
YOR198C BFR1 VVADDLVLVT(ph)PK 5.7514 0.001311 
YOR205C GEP3 Y(ph)AIPPFIGS(ph)IEIVLK 0.0040536 3.83E-19 
YOR217W RFC1 KMPVSNVIDVS(ph)ET(ph)PEGEK 5.0739 0.0026388 
YOR220W RCN2 NKPLLSINT(ph)DPGVTGVDSSSLNK 3.2771 0.021459 
YOR220W RCN2 NKPLLS(ph)INTDPGVTGVDSSSLNK 3.5556 0.015108 
YOR239W ABP140 TAEKPLETNLPKPETNEEDEEEGS(ph)MSENK 0.45399 0.094716 
YOR260W GCD1 DSTAATS(ph)GDKLNELVNSALDSTVINEFMQHSTR 0.21058 0.0021082 
YOR273C TPO4 THT(ph)QPVPASFDR 0.30206 0.041304 
YPL004C LSP1 ALLELLDDSPVT(ph)PGEARPAYDGYEASR 0.2247 0.0029868 
YPL058C PDR12 HLSNILS(ph)NEEGIER 3.4782 0.016639 
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YPL116W HOS3 TVEDIT(ph)IDDISR 0.29238 0.037258 
YPL150W   RVS(ph)SLLVEDGGNPTA 0.49401 NC  
YPL153C RAD53 DFS(ph)IIDEVAGQGAFATVKK 0.17558 0.00074691 
YPL160W CDC60 NFDNVPAEEEEIKEET(ph)PAEKDHEDVT(ph)K 0.26174 0.014125 
YPL160W CDC60 NFDNVPAEEEEIKEET(ph)PAEK 0.37355 0.052141 
YPL263C KEL3 TKS(ph)FELCEDR 0.3563 0.025487 
YPR019W MCM4 NNS(ph)QNLSQGEGNIR 0.41548 0.045909 
YPR093C ASR1 NSMIFAGELRDKHS(ph)VK 0.0019333 4.59E-24 
YPR137C-B   EVHTNQDPLDVSASKT(ph)EECEK 2.8097 0.039612 
YPR137C-B   EVHTNQDPLDVS(ph)ASK 3.3102 0.020571 
YPR160W GPH1 RLT(ph)GFLPQEIK 0.36207 0.047024 
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Chapter V 
Future Directions 
 
 
5.1. ProQ 
 Elucidation of the mechanism of action of ProQ will require three separate but 
complementary approaches: 1) Determination of the factors governing ProQ-ribosome 
association. 2) Compilation of a ProQ “regulatome”, and 3) Targeted probing of the 
circumstantial evidence linking RNase III and ProQ.  
 
5.1.1. Exploring the ProQ-mRNA-Ribosome interaction 
Data in Chapter II of this document presents evidence that the primary reason 
that ProQ is found in ribosomal fractions separated on sucrose gradients is because it 
binds to the mRNA being translated (Figure 2.3A and B). With that in mind, there also 
appears to be a small increase in ProQ cosedimentation with 30S subunits when 
translating ribosomes are dissociated (Figure 2.1B). Also, ProQ is found in detectable 
levels in fractions corresponding to mRNA-free ribosomal particles (Figure 2.3B). 
Together, this suggests that association with ribosomes is not strictly occurring via 
tethering by the mRNA. Therefore, it is necessary to firmly determine the 
interdependence of ProQ domains, mRNAs, and the ribosome on association. This will 
most likely require an in vitro approach, as mRNA must be removed from the system. In 
addition to working in vitro, discontinuation of the use of sucrose gradients must be 
considered. The forces and heat generated by long centrifugation times may cause  
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dissociation of weak interactions between ProQ and ribosomal particles. Potential 
replacement assays could include: far-western blotting of SDS-PAGE separated, or dot-
blotted, ribosomes, or fluorescence anisotropy. The large size of the ribosome makes 
other methods more technically challenging. To proceed, ribosomal particles, as well as 
individual domain constructs of ProQ (Figure 2.2A) would need to be purified. This is 
trivial. It seems reasonable to continue to use in vitro transcribed proP mRNAs to assay 
the dependence upon mRNA for ribosomal interaction, but in light of the facts discussed 
in Chapter II, rpoS must be reconsidered as a negative control. Any other mRNA not 
controlled by a sRNA would be a better choice. 
 
5.1.2. Identifying the ProQ regulatome 
A key piece of information hindering the elucidation of the role of ProQ in 
translation is a bona fide target. The data showing changes in ProP protein levels in a 
proQ mutant strain are, for lack of a better word, underwhelming. It is clear that proline 
import is down in these strains, but the published change ProP expression levels is very 
subtle. The ProP-independent effect of ProQ on biofilm formation is a promising lead in 
finding a true target. In addition, the almost complete loss of FliC in a proQ mutant is 
striking. Though this loss of FliC was not successfully complemented (Figure 2.10) it 
cannot yet be dismissed. Personal communication with other labs studying ProQ has 
indicated FliC as a potential target as well.  
Because of the advances in sequencing technology, the most reasonable way to 
move forward on finding more targets of ProQ regulation is to perform RNA-seq 
experiments. First, comparison of the relative abundance of individual RNAs between a 
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wild type strain and a ΔproQ strain would yield mRNAs and sRNAs which are 
(de)stabilized in the absence of ProQ. Since there are no current examples of ProQ 
functioning as an inhibitor of translation, I would expect that targets of ProQ would be 
found in lower abundance when ProQ is deleted, suggesting that they are not efficiently 
translated, and therefore degraded, or they are not protected from degradation by 
nucleases. A second, and more sophisticated, method would involve using either cross-
linking immunoprecipitation followed by deep sequencing (CLIP-Seq) or ribosome 
immunoprecipitation followed by deep sequencing (RIP-Seq). The former would yield 
RNAs which are bound to ProQ both independently and dependently of the ribosome. 
The latter would show mRNAs which IP with ProQ-associated ribosome. 
Once a list of putative targets is generated via one of the above methods, follow-
up analysis would include in vivo experiments to verify differential RNA levels. Northern 
blots could also be performed on polysome fractionations to probe for changes in 
ribosome occupancy of target mRNAs. It would also be profitable to mine targets for 
sequence determinants, as this may yield mechanistic details, as well. 
 
5.1.3. RNase III and ProQ 
The recent publication, discussed in Chapter II of this document, showing that 
proP mRNA transcribed from the distal P1 promoter is degraded by RNase III, suggests 
a link between ProQ and RNase III. In addition, the increase in fliC mRNA levels in an 
RNase III mutant background reinforces the antagonistic relationship between ProQ and 
RNase III. The simplest hypothesis is that ProQ binds to RNAs targeted for degradation 
by RNase III and precludes the nuclease from cleaving. However, the homology of 
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ProQ to FinO and Hfq must not be dismissed. As both of these proteins mediate sRNA-
RNA interactions, it seems likely that ProQ would behave in a similar manner. Similar to 
the DsrA/rpoS interaction described in Chapter I, ProQ may facilitate the binding 
between an sRNA and proP. This interaction may cause a change in the secondary 
structure of proP, dissolving the double-stranded RNase III cleavage site. In this way, 
proP mRNA would be stabilized and more efficiently translated. Testing of these 
hypotheses will again require discovery of true targets of ProQ-RNA binding. 
 
5.2. Ksp1p 
The continued study of Ksp1p will focus on several open questions. Not 
previously discussed is the fact that Ksp1p contains a prion-like domain which has been 
shown to be able to form aggregates in vivo [1]. Ksp1p also has a putative eIF4E 
binding domain [2]. It must be determined if these domains are important for Ksp1p 
regulation of pseudohyphal growth or mRNP granule formation. Next, direct targets of 
Ksp1p phosphorylation should be determined. The data presented in Chapter IV will 
guide these studies. Lastly, the recruitment of Ksp1p to stress granules may serve one 
of two purposes. It may be a mechanism to protect Ksp1p during stress, ensuring that 
once conditions are favorable, Ksp1p can again be active without delay, or it may serve 
to regulate Ksp1p kinase activity, either concentrating Ksp1p with its targets during 
stress, or similarly, sequestering it from targets. 
 
5.2.1. Probing of Ksp1p structural domains 
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The putative eIF4E (4E) binding domain of Ksp1p resides between residues 246 
and 252. I have already constructed a mutant which substitutes this entire region to 7 
alanines, and this mutant can be stably expressed and seen by western-blot analysis. 
Attempts to coimmunoprecipitate a T7- and His-tagged 4E with a c-terminally HA 
tagged Ksp1p resulted in non-specific binding of 4E to the anti-HA resin. Eventually, 
determining if Ksp1p and 4E interact in vivo fell outside of the scope of this project. 
Moving forward, the changing of epitope tags is a trivial matter which can be addressed. 
If changing tags does not optimize the assay, other methods could be used, including 
far-western blotting or yeast two-hybrid assays. The former would require purified 
components. For these purposes I have already constructed plasmids for over 
expression and purification of full length Ksp1p, and a truncated version of Ksp1p 
covering the N-terminal domain where the kinase activity and putative 4E binding site 
reside. 
Determining if Ksp1p forms functional prions in vivo is a more difficult question. 
The hallmark of prions is their non-Mendelian inheritance, and this can lead to highly 
variable results which make it difficult to draw solid conclusions. Formation of prions in 
yeast is dependent upon the activity of the chaperone Hsp104p [3]. Therefore, deletion 
of Hsp104p, or inhibition of its activity using chemical inhibitors such as guanidine 
hydrochloride (GuHCl), can cure yeast of prions [4]. Unfortunately, such a broad 
approach is unlikely to yield any useful data about Ksp1p. Any phenotypes seen in the 
presence of GuHCl or in an hsp104 mutant would likely be indirect. The predicted prion-
forming domain of Ksp1p lies between residues 400 and 625 [1]. Preliminary data, 
which again did not fall within the scope of this project, indicates that this region is not 
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necessary for Ksp1p to form cytoplasmic foci. However, examination of foci formation of 
GFP-tagged stress granule markers was altered in a ksp1 background when the c-
terminus was deleted after the 350th residue. The effects of this truncation on 
pseudohyphal growth were not studied, but they must be.  
 
5.2.2. Finding direct targets of Ksp1p phosphorylation 
The study presented in Chapter IV yielded 180 peptides with differential 
phosphorylation states in a ksp1 kinase dead mutant. Of these 180 peptides, 137 of 
them show decreased phosphorylation. As increased phosphorylation at a particular 
residue eliminates it as a direct target of Ksp1p, the focus can shift to these remaining 
proteins. Further trimming of the list must be done by looking at the specific residues 
and mining the literature for available information. The best choices for narrowing down 
the list include an online database dedicated to compiling all known phosphorylation 
sites, their kinases, and their motifs, called phosphoGRID [5]. A second resource comes 
from a high-throughput study of in vitro phosphorylation by yeast kinases [6]. To guide 
the search for direct targets, any Ksp1p-dependent phosphorylation sites found in 
phosphoGRID, for which the kinase is already know can potentially be eliminated, 
though it is possible that there is redundancy in the kinome. It may also be possible to 
trim the list further by eliminating sites which contain a consensus motif for a different 
kinase. Comparison of the remaining candidates to the dataset from the high-throughput 
study may yield overlapping proteins. If necessary, the data could be filtered again for 
proteins whose phosphorylation states are dependent upon PKA signaling. 
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Once the list is narrowed, it will be necessary to verify that the phosphorylation 
state of the candidate changes in vivo in a Ksp1p-dependent manner. This would be 
accomplished by looking for changes in phosphorylation states in different ksp1 mutant 
backgrounds. Also, phosphorylation will require a physical interaction, so 
immunoprecipitation would provide further evidence that a particular protein is a target 
of Ksp1p kinase activity. Lastly, it is necessary to show that phosphorylation of a target 
can happen in a purified system in vitro. This will require both proteins to be purified, but 
is fairly straight forward. 
 
5.2.3. Understanding the purpose for Ksp1p granule localization 
This final direction is one of great interest to the Kumar Lab, but it also the most 
difficult question to answer. As mentioned, the exact purpose for the formation of stress 
granules is not completely understood; though, there are many hypotheses. Similarly, it 
is not well understood why some proteins have evolved to localize to these aggregates 
during stress. Since the Kumar Lab is keenly interested in the kinase signaling networks 
which respond to stress, we would particularly like to understand why kinases localize to 
these mRNP granules. A favored hypothesis is that localization of a kinase to an 
aggregate of RNA and proteins may serve to concentrate the kinase and its targets, 
enhancing phosphorylation of the targets. This could also work in the opposite direction, 
as the kinase may be sequestered from its targets by aggregating while its targets 
remain free in the cytosol.  
Any progress made on this front, with respect to Ksp1p, will only come after a 
direct target is found, and a particular residue is identified as a bona fide Ksp1p target, 
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to the exclusion of all other kinases. It will then be beneficial to obtain phospho-specific 
antibodies to this target residue. In this way, we could monitor phosphorylation state of 
a particular residue under specific conditions. We can then ask questions to test these 
hypotheses. Questions include: What is the phosphorylation state during vegetative 
growth? How does the phosphorylation state change when cells are shifted to stress 
conditions? Do the two proteins colocalize in granules? Does mutation of the residue 
perturb the localization pattern during normal growth or stress conditions? The exact 
parameters of each experiment will depend on the identity of the target and the 
conditions necessary for phenotypic analysis. 
 
5.3. Conclusions 
Our understanding of ProQ and Ksp1p is starting to increase, but the details of 
the mechanisms by which they function are still very hazy. Both proteins merit further 
study. Determining the targets and mechanism of ProQ regulation will expand the 
understanding of messenger specific translation regulation in bacteria. The current 
literature places most of the onus of sRNA and mRNA-specific regulation on Hfq. In 
ProQ we find a protein which, while related to Hfq structurally, seems to function in a 
slightly different manner, under different conditions, and with distinct targets. 
For its part, Ksp1p plays a diverse, but seemingly non-essential, role in yeast. 
The dependency on Ksp1p during times of nutrient excess is likely minimal, but 
mutations of ksp1 manifest as defects in response to stress. As life outside of the 
laboratory is more volatile (if not for graduate students, at least for microorganisms), the 
need to cope with changing conditions is exaggerated. In addition to a greater 
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understanding of how yeast respond to stress, the role of Ksp1p in mRNP granule 
regulation makes further study imperative. To restate, improper regulation of the 
formation and clearing of these cytoplasmic aggregates have many implications in 
disease. Any insight gained by the study of the highly tractable yeast system is likely to 
be applicable to humans. 
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